GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf4
|
ENSRNOG00000016299 | Kruppel like factor 4 |
Sp3
|
ENSRNOG00000060479 | Sp3 transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Klf4 | rn6_v1_chr5_-_72287669_72287669 | 0.53 | 2.1e-24 | Click! |
Sp3 | rn6_v1_chr3_-_59688692_59688692 | 0.42 | 7.5e-15 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_-_56506446 | 128.46 |
ENSRNOT00000021357
|
Acap1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr1_-_142615673 | 122.63 |
ENSRNOT00000018021
|
Iqgap1
|
IQ motif containing GTPase activating protein 1 |
chr13_+_52976507 | 96.51 |
ENSRNOT00000090599
ENSRNOT00000011324 |
Kif21b
|
kinesin family member 21B |
chr1_-_80544825 | 89.81 |
ENSRNOT00000057802
ENSRNOT00000040060 ENSRNOT00000067049 ENSRNOT00000052387 ENSRNOT00000073352 |
Relb
|
RELB proto-oncogene, NF-kB subunit |
chr3_-_160802433 | 89.34 |
ENSRNOT00000076191
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr6_+_43829945 | 87.72 |
ENSRNOT00000086548
|
Klf11
|
Kruppel-like factor 11 |
chr1_-_7064870 | 84.28 |
ENSRNOT00000019983
|
Stx11
|
syntaxin 11 |
chr1_-_47331412 | 83.58 |
ENSRNOT00000046746
|
Ezr
|
ezrin |
chr20_-_22004209 | 81.64 |
ENSRNOT00000086250
ENSRNOT00000068778 |
Rtkn2
|
rhotekin 2 |
chr10_-_37645802 | 76.45 |
ENSRNOT00000008022
|
Tcf7
|
transcription factor 7 (T-cell specific, HMG-box) |
chrX_+_156463953 | 73.56 |
ENSRNOT00000079889
|
Flna
|
filamin A |
chr14_-_1461543 | 69.17 |
ENSRNOT00000075656
|
Crlf2
|
cytokine receptor-like factor 2 |
chr2_+_77868412 | 68.44 |
ENSRNOT00000065897
ENSRNOT00000014022 |
Myo10
|
myosin X |
chr2_-_183031214 | 68.40 |
ENSRNOT00000013260
|
LOC679811
|
similar to RIKEN cDNA D930015E06 |
chr3_-_160738927 | 65.40 |
ENSRNOT00000043470
|
Slpil2
|
antileukoproteinase-like 2 |
chr3_+_164822111 | 64.52 |
ENSRNOT00000014568
|
Pard6b
|
par-6 family cell polarity regulator beta |
chr3_-_2136936 | 63.16 |
ENSRNOT00000010169
|
Arrdc1
|
arrestin domain containing 1 |
chr5_+_151413382 | 62.84 |
ENSRNOT00000012626
|
Cd164l2
|
CD164 molecule like 2 |
chr3_-_160739137 | 62.71 |
ENSRNOT00000075836
|
Slpil2
|
antileukoproteinase-like 2 |
chr3_-_160139947 | 62.05 |
ENSRNOT00000014151
|
Ada
|
adenosine deaminase |
chr20_-_3397039 | 61.88 |
ENSRNOT00000001084
ENSRNOT00000085259 |
Ppp1r18
|
protein phosphatase 1, regulatory subunit 18 |
chr12_+_2180150 | 61.81 |
ENSRNOT00000001322
|
Stxbp2
|
syntaxin binding protein 2 |
chr2_+_252018597 | 59.91 |
ENSRNOT00000020452
|
Mcoln2
|
mucolipin 2 |
chr4_-_100883038 | 57.96 |
ENSRNOT00000041880
|
LOC100364435
|
thymosin, beta 10-like |
chr6_-_55001464 | 57.80 |
ENSRNOT00000006618
|
Ahr
|
aryl hydrocarbon receptor |
chr9_-_17835240 | 55.26 |
ENSRNOT00000026988
|
Nfkbie
|
NFKB inhibitor epsilon |
chr9_-_27192135 | 54.41 |
ENSRNOT00000017592
|
Tram2
|
translocation associated membrane protein 2 |
chr12_+_40244081 | 54.39 |
ENSRNOT00000030583
|
Sh2b3
|
SH2B adaptor protein 3 |
chr18_+_63016761 | 53.31 |
ENSRNOT00000081432
|
Impa2
|
inositol monophosphatase 2 |
chr10_-_105600913 | 53.04 |
ENSRNOT00000068026
|
Rhbdf2
|
rhomboid 5 homolog 2 |
chr4_+_100407658 | 52.69 |
ENSRNOT00000018562
|
Capg
|
capping actin protein, gelsolin like |
chr7_+_130474279 | 52.66 |
ENSRNOT00000092388
|
Shank3
|
SH3 and multiple ankyrin repeat domains 3 |
chr18_+_63016577 | 52.16 |
ENSRNOT00000025147
|
Impa2
|
inositol monophosphatase 2 |
chr10_+_106812739 | 51.96 |
ENSRNOT00000074225
|
Syngr2
|
synaptogyrin 2 |
chr10_-_104628676 | 51.58 |
ENSRNOT00000010466
|
Unc13d
|
unc-13 homolog D |
chr1_+_256745288 | 51.38 |
ENSRNOT00000022133
|
Cep55
|
centrosomal protein 55 |
chr7_-_119071712 | 50.96 |
ENSRNOT00000037611
|
Myh9l1
|
myosin heavy chain 9-like 1 |
chr8_-_62424303 | 50.95 |
ENSRNOT00000091223
|
Csk
|
c-src tyrosine kinase |
chr19_-_52499433 | 50.75 |
ENSRNOT00000021954
|
Cotl1
|
coactosin-like F-actin binding protein 1 |
chr1_-_87155118 | 50.73 |
ENSRNOT00000072441
|
AABR07002854.1
|
|
chr5_+_155812105 | 50.66 |
ENSRNOT00000039341
|
AABR07073181.1
|
|
chr13_+_111870121 | 50.38 |
ENSRNOT00000007333
|
Irf6
|
interferon regulatory factor 6 |
chr7_+_120580743 | 50.17 |
ENSRNOT00000017181
|
Maff
|
MAF bZIP transcription factor F |
chr2_-_203680083 | 50.11 |
ENSRNOT00000021268
|
Cd2
|
Cd2 molecule |
chr19_+_37476095 | 49.76 |
ENSRNOT00000092794
ENSRNOT00000023130 |
Hsd11b2
|
hydroxysteroid 11-beta dehydrogenase 2 |
chr2_+_209097927 | 49.65 |
ENSRNOT00000023807
|
Dennd2d
|
DENN domain containing 2D |
chr3_+_150323116 | 49.64 |
ENSRNOT00000023429
ENSRNOT00000080485 |
Raly
|
RALY heterogeneous nuclear ribonucleoprotein |
chr5_-_76756140 | 49.01 |
ENSRNOT00000022107
ENSRNOT00000089251 |
Ptbp3
|
polypyrimidine tract binding protein 3 |
chr2_-_116161998 | 48.75 |
ENSRNOT00000012560
|
Gpr160
|
G protein-coupled receptor 160 |
chr11_+_86092468 | 48.29 |
ENSRNOT00000057971
|
LOC100361706
|
lambda-chain C1-region-like |
chr16_+_69048730 | 48.17 |
ENSRNOT00000086082
ENSRNOT00000078128 |
Rab11fip1
|
RAB11 family interacting protein 1 |
chr2_-_202816562 | 48.12 |
ENSRNOT00000020401
|
Fam46c
|
family with sequence similarity 46, member C |
chr20_-_3401273 | 48.08 |
ENSRNOT00000089257
ENSRNOT00000078451 ENSRNOT00000001085 |
Nrm
|
nurim (nuclear envelope membrane protein) |
chr7_-_14189688 | 48.05 |
ENSRNOT00000037456
|
Notch3
|
notch 3 |
chr8_+_99625545 | 47.75 |
ENSRNOT00000010689
ENSRNOT00000056727 |
Plscr1
|
phospholipid scramblase 1 |
chr3_+_111049315 | 47.68 |
ENSRNOT00000017223
|
Spint1
|
serine peptidase inhibitor, Kunitz type 1 |
chr4_-_100883275 | 47.17 |
ENSRNOT00000022846
|
LOC100364435
|
thymosin, beta 10-like |
chr16_+_17538855 | 47.16 |
ENSRNOT00000014772
|
Tspan14
|
tetraspanin 14 |
chr1_-_142020525 | 47.08 |
ENSRNOT00000042558
|
Cib1
|
calcium and integrin binding 1 |
chr1_-_198460126 | 46.90 |
ENSRNOT00000082940
ENSRNOT00000086019 |
Maz
|
MYC associated zinc finger protein |
chr3_+_171037957 | 46.70 |
ENSRNOT00000008764
|
Rbm38
|
RNA binding motif protein 38 |
chr5_+_133221139 | 46.50 |
ENSRNOT00000047522
|
Trabd2b
|
TraB domain containing 2B |
chr5_+_105230580 | 46.09 |
ENSRNOT00000010056
|
Acer2
|
alkaline ceramidase 2 |
chr14_+_91782354 | 45.77 |
ENSRNOT00000005902
|
Ikzf1
|
IKAROS family zinc finger 1 |
chr12_+_48481750 | 45.74 |
ENSRNOT00000000886
|
Coro1c
|
coronin 1C |
chr7_-_119797098 | 45.70 |
ENSRNOT00000009994
|
Rac2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chrX_+_65226748 | 45.48 |
ENSRNOT00000076181
|
Msn
|
moesin |
chr3_+_119776925 | 44.55 |
ENSRNOT00000018549
|
Dusp2
|
dual specificity phosphatase 2 |
chr1_+_141391262 | 44.54 |
ENSRNOT00000031783
|
Ticrr
|
TOPBP1-interacting checkpoint and replication regulator |
chr5_-_58987760 | 44.51 |
ENSRNOT00000035040
|
Sit1
|
signaling threshold regulating transmembrane adaptor 1 |
chr1_+_266053002 | 44.49 |
ENSRNOT00000026235
|
Nfkb2
|
nuclear factor kappa B subunit 2 |
chr10_-_88060561 | 44.49 |
ENSRNOT00000019133
|
Krt19
|
keratin 19 |
chr1_+_142087208 | 44.37 |
ENSRNOT00000017532
|
Prc1
|
protein regulator of cytokinesis 1 |
chr7_-_144880092 | 44.19 |
ENSRNOT00000055281
|
Nfe2
|
nuclear factor, erythroid 2 |
chr3_+_111049118 | 44.01 |
ENSRNOT00000088870
|
Spint1
|
serine peptidase inhibitor, Kunitz type 1 |
chr5_+_171472273 | 43.87 |
ENSRNOT00000055386
|
LOC100911486
|
multiple epidermal growth factor-like domains protein 6-like |
chr12_-_11265865 | 43.84 |
ENSRNOT00000001315
|
Arpc1b
|
actin related protein 2/3 complex, subunit 1B |
chr13_-_95943761 | 43.63 |
ENSRNOT00000005961
|
Adss
|
adenylosuccinate synthase |
chr2_+_165601007 | 43.39 |
ENSRNOT00000013931
|
Smc4
|
structural maintenance of chromosomes 4 |
chr1_-_80315533 | 43.21 |
ENSRNOT00000082928
|
Klc3
|
kinesin light chain 3 |
chr6_-_26486695 | 43.15 |
ENSRNOT00000073236
|
Krtcap3
|
keratinocyte associated protein 3 |
chr18_-_399242 | 43.07 |
ENSRNOT00000045926
|
F8
|
coagulation factor VIII |
chr12_-_22138382 | 43.01 |
ENSRNOT00000001899
|
Lrch4
|
leucine rich repeats and calponin homology domain containing 4 |
chr3_-_92783569 | 42.81 |
ENSRNOT00000009073
ENSRNOT00000009000 |
Cd44
|
CD44 molecule (Indian blood group) |
chr10_+_103713045 | 42.81 |
ENSRNOT00000004351
|
Slc9a3r1
|
SLC9A3 regulator 1 |
chr3_-_138116664 | 42.51 |
ENSRNOT00000055602
|
Rrbp1
|
ribosome binding protein 1 |
chr7_-_75422268 | 42.27 |
ENSRNOT00000080218
|
Pabpc1
|
poly(A) binding protein, cytoplasmic 1 |
chr14_+_84417320 | 42.27 |
ENSRNOT00000008788
|
Tbc1d10a
|
TBC1 domain family, member 10a |
chr7_-_12673659 | 41.92 |
ENSRNOT00000091650
ENSRNOT00000041277 ENSRNOT00000044865 |
Ptbp1
|
polypyrimidine tract binding protein 1 |
chr9_-_9985358 | 41.91 |
ENSRNOT00000080856
|
Crb3
|
crumbs 3, cell polarity complex component |
chr7_-_70969905 | 41.78 |
ENSRNOT00000057745
|
Nab2
|
Ngfi-A binding protein 2 |
chr5_-_24631679 | 41.33 |
ENSRNOT00000010846
ENSRNOT00000067129 |
Esrp1
|
epithelial splicing regulatory protein 1 |
chr11_-_37914983 | 41.32 |
ENSRNOT00000039876
|
Mx1
|
myxovirus (influenza virus) resistance 1 |
chr3_-_160730360 | 41.23 |
ENSRNOT00000075864
|
RGD1563818
|
similar to secretory leukocyte protease inhibitor |
chr8_+_5967463 | 41.09 |
ENSRNOT00000086251
|
Tmem123
|
transmembrane protein 123 |
chr3_-_81282157 | 40.91 |
ENSRNOT00000051258
|
Large2
|
LARGE xylosyl- and glucuronyltransferase 2 |
chr20_+_13670066 | 40.88 |
ENSRNOT00000031400
|
LOC103694874
|
stromelysin-3 |
chr20_-_4921348 | 40.80 |
ENSRNOT00000082497
ENSRNOT00000041151 |
RT1-CE4
|
RT1 class I, locus CE4 |
chr9_+_98190829 | 40.66 |
ENSRNOT00000050191
|
Lrrfip1
|
LRR binding FLII interacting protein 1 |
chr5_+_172986291 | 40.63 |
ENSRNOT00000022900
|
Nadk
|
NAD kinase |
chr3_-_172537877 | 40.38 |
ENSRNOT00000072069
|
Ctsz
|
cathepsin Z |
chr8_-_71118927 | 40.26 |
ENSRNOT00000042633
|
Plekho2
|
pleckstrin homology domain containing O2 |
chr1_-_89329185 | 40.26 |
ENSRNOT00000078284
|
Cd22
|
CD22 molecule |
chr18_-_63488027 | 40.16 |
ENSRNOT00000023763
|
Ptpn2
|
protein tyrosine phosphatase, non-receptor type 2 |
chr5_-_24255606 | 40.02 |
ENSRNOT00000037483
|
Plekhf2
|
pleckstrin homology and FYVE domain containing 2 |
chr4_-_81968832 | 39.48 |
ENSRNOT00000016608
|
Skap2
|
src kinase associated phosphoprotein 2 |
chr3_-_113405829 | 39.31 |
ENSRNOT00000036823
|
Ell3
|
elongation factor for RNA polymerase II 3 |
chr10_-_15125408 | 39.22 |
ENSRNOT00000026395
|
Msln
|
mesothelin |
chr5_-_126856292 | 39.20 |
ENSRNOT00000013575
|
Lrrc42
|
leucine rich repeat containing 42 |
chr8_-_61079526 | 39.05 |
ENSRNOT00000068658
|
Peak1
|
pseudopodium-enriched atypical kinase 1 |
chr1_+_191704311 | 39.04 |
ENSRNOT00000024057
|
Scnn1g
|
sodium channel epithelial 1 gamma subunit |
chr7_-_119996824 | 38.97 |
ENSRNOT00000011079
|
Mfng
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
chr13_+_109713489 | 38.93 |
ENSRNOT00000004962
|
Batf3
|
basic leucine zipper ATF-like transcription factor 3 |
chr5_-_57168610 | 38.35 |
ENSRNOT00000090499
|
B4galt1
|
beta-1,4-galactosyltransferase 1 |
chrX_+_156873849 | 38.17 |
ENSRNOT00000085410
|
Arhgap4
|
Rho GTPase activating protein 4 |
chr1_+_198744050 | 38.06 |
ENSRNOT00000024404
|
Itgal
|
integrin subunit alpha L |
chr19_-_55257876 | 38.04 |
ENSRNOT00000017564
|
Cyba
|
cytochrome b-245 alpha chain |
chr12_-_21832813 | 37.95 |
ENSRNOT00000075280
|
Cldn3
|
claudin 3 |
chr2_-_31826867 | 37.85 |
ENSRNOT00000025687
|
Pik3r1
|
phosphoinositide-3-kinase regulatory subunit 1 |
chr18_+_65814026 | 37.85 |
ENSRNOT00000016112
|
Mbd2
|
methyl-CpG binding domain protein 2 |
chr6_+_12253788 | 37.62 |
ENSRNOT00000061675
|
Ppp1r21
|
protein phosphatase 1, regulatory subunit 21 |
chr8_+_55279373 | 37.59 |
ENSRNOT00000064290
|
Ppp2r1b
|
protein phosphatase 2 scaffold subunit A beta |
chr10_+_94170766 | 37.32 |
ENSRNOT00000010627
|
Ace
|
angiotensin I converting enzyme |
chr7_-_75421874 | 37.17 |
ENSRNOT00000012775
|
Pabpc1
|
poly(A) binding protein, cytoplasmic 1 |
chr14_+_1462358 | 37.01 |
ENSRNOT00000077243
|
Csf2ra
|
colony stimulating factor 2 receptor alpha subunit |
chr3_+_123731539 | 36.85 |
ENSRNOT00000051064
|
Cdc25b
|
cell division cycle 25B |
chr12_+_23473270 | 36.68 |
ENSRNOT00000001935
|
Sh2b2
|
SH2B adaptor protein 2 |
chr7_+_12782491 | 36.63 |
ENSRNOT00000065093
|
Cnn2
|
calponin 2 |
chr1_-_82610350 | 36.60 |
ENSRNOT00000028177
|
Cyp2s1
|
cytochrome P450, family 2, subfamily s, polypeptide 1 |
chr14_+_3058993 | 36.59 |
ENSRNOT00000002807
|
Gfi1
|
growth factor independent 1 transcriptional repressor |
chr2_-_125323454 | 36.51 |
ENSRNOT00000045837
|
Ankrd50
|
ankyrin repeat domain 50 |
chr12_+_12227010 | 36.39 |
ENSRNOT00000060843
ENSRNOT00000092610 |
Baiap2l1
|
BAI1-associated protein 2-like 1 |
chr5_-_152122542 | 36.37 |
ENSRNOT00000068634
ENSRNOT00000077248 |
Rps6ka1
|
ribosomal protein S6 kinase A1 |
chr16_+_48863418 | 36.29 |
ENSRNOT00000029868
|
Primpol
|
primase and DNA directed polymerase |
chr1_-_87221826 | 36.20 |
ENSRNOT00000046611
ENSRNOT00000028006 |
Spint2
|
serine peptidase inhibitor, Kunitz type, 2 |
chr10_+_14547172 | 36.03 |
ENSRNOT00000092043
|
Unkl
|
unkempt family like zinc finger |
chr5_+_154552195 | 35.95 |
ENSRNOT00000072864
|
Asap3
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 |
chr7_+_70946228 | 35.92 |
ENSRNOT00000039306
|
Stat6
|
signal transducer and activator of transcription 6 |
chr16_+_10417185 | 35.75 |
ENSRNOT00000082186
|
Anxa8
|
annexin A8 |
chr13_+_27465930 | 35.58 |
ENSRNOT00000003314
|
Serpinb10
|
serpin family B member 10 |
chr13_+_34610684 | 35.48 |
ENSRNOT00000093019
ENSRNOT00000003280 |
Tfcp2l1
|
transcription factor CP2-like 1 |
chr9_-_78368777 | 35.46 |
ENSRNOT00000020414
|
Bard1
|
BRCA1 associated RING domain 1 |
chr10_+_55013703 | 35.36 |
ENSRNOT00000032785
|
Pik3r5
|
phosphoinositide-3-kinase, regulatory subunit 5 |
chr3_-_14538241 | 35.32 |
ENSRNOT00000025904
|
Stom
|
stomatin |
chr1_-_64446818 | 35.32 |
ENSRNOT00000081980
|
Myadm
|
myeloid-associated differentiation marker |
chr1_+_165506361 | 35.31 |
ENSRNOT00000024156
|
Ucp2
|
uncoupling protein 2 |
chr6_+_33885495 | 35.29 |
ENSRNOT00000086633
|
Sdc1
|
syndecan 1 |
chr1_+_85324079 | 35.15 |
ENSRNOT00000093693
|
Samd4b
|
sterile alpha motif domain containing 4B |
chr9_-_60430081 | 35.03 |
ENSRNOT00000016856
|
Stk17b
|
serine/threonine kinase 17b |
chr10_+_63803309 | 34.97 |
ENSRNOT00000036666
|
Myo1c
|
myosin 1C |
chr10_+_4719713 | 34.93 |
ENSRNOT00000003412
|
Litaf
|
lipopolysaccharide-induced TNF factor |
chr3_+_148579920 | 34.86 |
ENSRNOT00000012432
|
Hck
|
HCK proto-oncogene, Src family tyrosine kinase |
chr5_+_151181559 | 34.73 |
ENSRNOT00000085674
|
Fgr
|
FGR proto-oncogene, Src family tyrosine kinase |
chr1_-_146289465 | 34.70 |
ENSRNOT00000017362
|
Abhd17c
|
abhydrolase domain containing 17C |
chr1_-_89329418 | 34.47 |
ENSRNOT00000033155
|
Cd22
|
CD22 molecule |
chr13_+_26903052 | 34.47 |
ENSRNOT00000003625
|
Serpinb5
|
serpin family B member 5 |
chr6_+_51662224 | 34.43 |
ENSRNOT00000060006
|
Ccdc71l
|
coiled-coil domain containing 71-like |
chr16_-_20890949 | 34.42 |
ENSRNOT00000081977
|
Homer3
|
homer scaffolding protein 3 |
chr19_+_37260469 | 34.37 |
ENSRNOT00000021362
|
Elmo3
|
engulfment and cell motility 3 |
chr10_+_39109522 | 34.30 |
ENSRNOT00000010968
|
Irf1
|
interferon regulatory factor 1 |
chr7_+_11077411 | 34.26 |
ENSRNOT00000007117
|
S1pr4
|
sphingosine-1-phosphate receptor 4 |
chr4_-_62438958 | 34.25 |
ENSRNOT00000014010
|
Wdr91
|
WD repeat domain 91 |
chr7_+_114724610 | 34.24 |
ENSRNOT00000014541
|
Dennd3
|
DENN domain containing 3 |
chr4_-_113866674 | 34.05 |
ENSRNOT00000010020
|
Dok1
|
docking protein 1 |
chr4_-_157263890 | 33.92 |
ENSRNOT00000065416
|
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr8_-_22874637 | 33.92 |
ENSRNOT00000064551
ENSRNOT00000090424 |
Dock6
|
dedicator of cytokinesis 6 |
chr6_-_11298216 | 33.81 |
ENSRNOT00000021135
|
Epcam
|
epithelial cell adhesion molecule |
chr5_+_157282669 | 33.67 |
ENSRNOT00000022827
|
Pla2g2a
|
phospholipase A2 group IIA |
chr10_-_90356242 | 33.65 |
ENSRNOT00000028496
|
Slc25a39
|
solute carrier family 25, member 39 |
chr20_+_4357733 | 33.64 |
ENSRNOT00000000509
|
Pbx2
|
PBX homeobox 2 |
chr20_+_8165307 | 33.61 |
ENSRNOT00000000637
|
Pim1
|
Pim-1 proto-oncogene, serine/threonine kinase |
chr13_+_70174936 | 33.52 |
ENSRNOT00000064068
ENSRNOT00000079861 ENSRNOT00000092562 |
Arpc5
|
actin related protein 2/3 complex, subunit 5 |
chr4_+_85551502 | 33.51 |
ENSRNOT00000087191
ENSRNOT00000015692 |
Aqp1
|
aquaporin 1 |
chr20_+_5527181 | 33.48 |
ENSRNOT00000091364
|
Phf1
|
PHD finger protein 1 |
chr3_-_124610267 | 33.47 |
ENSRNOT00000028883
|
Rassf2
|
Ras association domain family member 2 |
chrX_+_15598652 | 33.31 |
ENSRNOT00000082383
|
Ccdc120
|
coiled-coil domain containing 120 |
chr10_-_94460732 | 33.06 |
ENSRNOT00000014508
|
Smarcd2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 |
chr15_+_24153602 | 33.03 |
ENSRNOT00000014216
|
Lgals3
|
galectin 3 |
chr15_+_57241968 | 32.98 |
ENSRNOT00000082191
|
Lcp1
|
lymphocyte cytosolic protein 1 |
chr5_-_144176807 | 32.87 |
ENSRNOT00000045841
|
Sh3d21
|
SH3 domain containing 21 |
chr1_+_31967978 | 32.79 |
ENSRNOT00000081471
ENSRNOT00000021532 |
Trip13
|
thyroid hormone receptor interactor 13 |
chr20_+_9743269 | 32.65 |
ENSRNOT00000001533
ENSRNOT00000083505 |
Abcg1
|
ATP binding cassette subfamily G member 1 |
chr1_+_191829555 | 32.61 |
ENSRNOT00000067138
|
Scnn1b
|
sodium channel epithelial 1 beta subunit |
chr1_-_212330349 | 32.60 |
ENSRNOT00000024369
|
Adam8
|
ADAM metallopeptidase domain 8 |
chr4_+_71740532 | 32.57 |
ENSRNOT00000023537
|
Zyx
|
zyxin |
chr1_+_221673590 | 32.54 |
ENSRNOT00000038016
|
Cdc42bpg
|
CDC42 binding protein kinase gamma |
chr5_+_63056089 | 32.42 |
ENSRNOT00000081090
|
Tgfbr1
|
transforming growth factor, beta receptor 1 |
chr16_-_36080191 | 32.40 |
ENSRNOT00000017635
|
Hmgb2l1
|
high mobility group box 2-like 1 |
chr14_-_82287706 | 32.38 |
ENSRNOT00000080695
|
Fgfr3
|
fibroblast growth factor receptor 3 |
chr4_-_119714302 | 32.31 |
ENSRNOT00000013299
|
Rab43
|
RAB43, member RAS oncogene family |
chr1_-_198577226 | 32.24 |
ENSRNOT00000055013
|
Spn
|
sialophorin |
chr5_+_154522119 | 32.20 |
ENSRNOT00000072618
|
E2f2
|
E2F transcription factor 2 |
chr2_+_252090669 | 32.10 |
ENSRNOT00000020656
|
Lpar3
|
lysophosphatidic acid receptor 3 |
chr5_+_74874306 | 32.02 |
ENSRNOT00000076918
|
Akap2
|
A-kinase anchoring protein 2 |
chr14_-_7384876 | 32.02 |
ENSRNOT00000086694
|
Aff1
|
AF4/FMR2 family, member 1 |
chr3_+_94035905 | 31.97 |
ENSRNOT00000014767
|
RGD1563222
|
similar to RIKEN cDNA A930018P22 |
chr10_+_40438356 | 31.87 |
ENSRNOT00000078910
|
Gm2a
|
GM2 ganglioside activator |
chr10_-_82887497 | 31.79 |
ENSRNOT00000005644
|
Itga3
|
integrin subunit alpha 3 |
chr10_-_85049331 | 31.76 |
ENSRNOT00000012538
|
Tbx21
|
T-box 21 |
chr1_-_163129641 | 31.66 |
ENSRNOT00000083055
|
Capn5
|
calpain 5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
30.6 | 152.8 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
29.9 | 89.6 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
29.3 | 176.0 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
28.6 | 28.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
28.1 | 84.3 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) |
26.5 | 132.7 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
25.6 | 76.7 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
24.7 | 74.1 | GO:0002432 | granuloma formation(GO:0002432) |
22.4 | 22.4 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
21.2 | 63.6 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
20.8 | 62.5 | GO:0071461 | cellular response to redox state(GO:0071461) |
19.6 | 78.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
19.6 | 78.3 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
19.3 | 77.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
18.6 | 55.9 | GO:1905071 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
18.6 | 74.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
17.8 | 53.4 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
17.7 | 35.3 | GO:0003192 | mitral valve formation(GO:0003192) |
17.2 | 34.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
16.8 | 67.0 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
16.7 | 83.5 | GO:1904717 | regulation of AMPA glutamate receptor clustering(GO:1904717) |
16.2 | 48.5 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
16.1 | 48.3 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
15.9 | 47.7 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
15.7 | 31.3 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
15.6 | 62.3 | GO:0030221 | basophil differentiation(GO:0030221) |
15.5 | 46.4 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
15.2 | 91.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
15.0 | 89.9 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
14.9 | 44.7 | GO:0072237 | metanephric proximal tubule development(GO:0072237) |
14.9 | 59.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
14.9 | 59.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
14.8 | 59.2 | GO:2000814 | positive regulation of barbed-end actin filament capping(GO:2000814) |
14.4 | 86.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
14.4 | 86.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
14.3 | 42.9 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
14.0 | 14.0 | GO:1905072 | cardiac jelly development(GO:1905072) |
14.0 | 55.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
14.0 | 69.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
13.8 | 41.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
13.7 | 54.9 | GO:0072268 | specification of loop of Henle identity(GO:0072086) pattern specification involved in metanephros development(GO:0072268) |
13.6 | 67.9 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
13.5 | 94.8 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
13.5 | 27.1 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
13.4 | 40.3 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
13.3 | 106.5 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
13.2 | 39.6 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
12.9 | 38.6 | GO:0071640 | regulation of macrophage inflammatory protein 1 alpha production(GO:0071640) |
12.9 | 12.9 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
12.8 | 38.5 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
12.8 | 25.5 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
12.6 | 239.8 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
12.6 | 12.6 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
12.2 | 61.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
12.2 | 36.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
12.2 | 36.6 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
12.1 | 60.7 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
12.1 | 24.3 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
12.0 | 120.4 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
11.9 | 35.8 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
11.5 | 34.4 | GO:0072714 | response to selenite ion(GO:0072714) |
11.5 | 57.3 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
11.3 | 45.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
11.3 | 33.9 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
11.2 | 22.5 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
11.2 | 11.2 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
11.0 | 33.0 | GO:1903769 | negative regulation of cell proliferation in bone marrow(GO:1903769) |
10.9 | 32.7 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
10.9 | 21.7 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
10.9 | 32.6 | GO:2000410 | activation of MAPK activity involved in innate immune response(GO:0035419) regulation of thymocyte migration(GO:2000410) |
10.9 | 32.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
10.8 | 32.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
10.8 | 43.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
10.8 | 161.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
10.7 | 10.7 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
10.7 | 21.5 | GO:0009609 | response to symbiotic bacterium(GO:0009609) |
10.7 | 42.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
10.7 | 53.3 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
10.7 | 32.0 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
10.6 | 31.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
10.5 | 10.5 | GO:0021571 | rhombomere 5 development(GO:0021571) |
10.5 | 31.5 | GO:0098749 | cerebellar neuron development(GO:0098749) |
10.5 | 31.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
10.5 | 20.9 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
10.3 | 30.9 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
10.2 | 10.2 | GO:0003342 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
10.2 | 30.7 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
10.2 | 40.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
10.2 | 71.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
10.1 | 20.2 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
10.1 | 50.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
10.0 | 30.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
10.0 | 20.0 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
9.9 | 49.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
9.9 | 69.3 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
9.7 | 38.8 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
9.7 | 67.9 | GO:0007144 | female meiosis I(GO:0007144) |
9.7 | 19.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
9.7 | 29.0 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
9.6 | 28.8 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
9.6 | 96.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
9.6 | 19.2 | GO:2000373 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
9.5 | 38.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
9.5 | 9.5 | GO:0019046 | viral latency(GO:0019042) release from viral latency(GO:0019046) |
9.4 | 121.8 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
9.4 | 18.7 | GO:0035772 | interleukin-13-mediated signaling pathway(GO:0035772) |
9.3 | 56.1 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
9.3 | 84.1 | GO:0009301 | snRNA transcription(GO:0009301) |
9.3 | 9.3 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
9.3 | 37.3 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
9.3 | 93.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
9.3 | 9.3 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
9.2 | 36.7 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
9.1 | 9.1 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
9.0 | 18.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
9.0 | 35.9 | GO:0048865 | stem cell fate commitment(GO:0048865) |
8.9 | 53.6 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
8.9 | 17.8 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
8.9 | 26.6 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
8.8 | 44.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
8.8 | 17.6 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
8.8 | 43.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
8.8 | 26.3 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
8.7 | 121.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
8.7 | 17.3 | GO:0036337 | Fas signaling pathway(GO:0036337) |
8.6 | 34.5 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
8.6 | 60.3 | GO:0035912 | dorsal aorta morphogenesis(GO:0035912) |
8.5 | 25.6 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
8.5 | 34.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
8.5 | 127.9 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
8.5 | 25.5 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
8.4 | 25.3 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
8.4 | 33.6 | GO:0034696 | response to prostaglandin F(GO:0034696) |
8.4 | 25.2 | GO:0046512 | sphingosine biosynthetic process(GO:0046512) |
8.4 | 8.4 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
8.3 | 49.9 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
8.3 | 33.2 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
8.2 | 32.9 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
8.2 | 16.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
8.2 | 32.8 | GO:0070370 | cellular heat acclimation(GO:0070370) |
8.2 | 41.0 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
8.2 | 65.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
8.2 | 32.7 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
8.2 | 49.0 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
8.1 | 8.1 | GO:0090024 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
8.1 | 16.3 | GO:1903165 | response to polycyclic arene(GO:1903165) |
8.1 | 64.8 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
8.1 | 32.4 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
8.1 | 24.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
8.1 | 56.4 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
8.0 | 24.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
8.0 | 40.0 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
7.9 | 15.9 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
7.9 | 111.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
7.9 | 15.7 | GO:0043366 | beta selection(GO:0043366) |
7.8 | 15.6 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
7.8 | 15.6 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
7.8 | 7.8 | GO:0060374 | mast cell differentiation(GO:0060374) |
7.8 | 46.7 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
7.7 | 23.2 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
7.7 | 38.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
7.7 | 38.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
7.7 | 30.6 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
7.6 | 22.9 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
7.6 | 61.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
7.6 | 7.6 | GO:0070384 | Harderian gland development(GO:0070384) |
7.6 | 15.2 | GO:1902946 | protein localization to early endosome(GO:1902946) |
7.6 | 30.2 | GO:0070673 | response to interleukin-18(GO:0070673) |
7.5 | 37.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
7.5 | 22.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
7.4 | 14.8 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
7.4 | 29.6 | GO:0021747 | cochlear nucleus development(GO:0021747) |
7.4 | 14.8 | GO:0030578 | PML body organization(GO:0030578) |
7.4 | 14.8 | GO:0033622 | integrin activation(GO:0033622) |
7.4 | 59.0 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
7.4 | 14.7 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
7.3 | 22.0 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
7.3 | 73.2 | GO:0002467 | germinal center formation(GO:0002467) |
7.3 | 14.6 | GO:0061198 | fungiform papilla formation(GO:0061198) |
7.3 | 29.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
7.2 | 14.3 | GO:0036166 | phenotypic switching(GO:0036166) |
7.2 | 21.5 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
7.1 | 28.5 | GO:0002159 | desmosome assembly(GO:0002159) |
7.1 | 35.6 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
7.1 | 21.3 | GO:0060101 | negative regulation of phagocytosis, engulfment(GO:0060101) |
7.1 | 28.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
7.1 | 70.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
7.1 | 35.4 | GO:1902414 | protein localization to cell junction(GO:1902414) |
7.1 | 28.2 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
7.0 | 35.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
7.0 | 7.0 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
7.0 | 21.0 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
7.0 | 21.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
7.0 | 55.8 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
7.0 | 13.9 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
6.9 | 69.5 | GO:0072540 | T-helper cell lineage commitment(GO:0002295) alpha-beta T cell lineage commitment(GO:0002363) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) T-helper 17 cell lineage commitment(GO:0072540) |
6.9 | 27.7 | GO:0014028 | notochord formation(GO:0014028) |
6.9 | 27.5 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
6.9 | 6.9 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
6.9 | 48.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
6.9 | 27.5 | GO:0071283 | cellular response to iron(III) ion(GO:0071283) |
6.9 | 48.0 | GO:0090166 | Golgi disassembly(GO:0090166) |
6.8 | 68.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
6.8 | 94.7 | GO:0051014 | actin filament severing(GO:0051014) |
6.8 | 20.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
6.7 | 47.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
6.7 | 6.7 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
6.7 | 6.7 | GO:0071307 | cellular response to vitamin K(GO:0071307) |
6.6 | 26.6 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
6.6 | 46.4 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
6.6 | 178.9 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
6.6 | 72.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
6.6 | 19.7 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
6.6 | 19.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
6.5 | 13.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
6.5 | 39.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
6.5 | 39.0 | GO:1902969 | mitotic DNA replication(GO:1902969) |
6.4 | 32.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
6.4 | 38.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
6.4 | 25.6 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
6.4 | 38.4 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
6.4 | 19.2 | GO:0060486 | Clara cell differentiation(GO:0060486) |
6.4 | 6.4 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
6.4 | 19.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
6.4 | 25.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
6.3 | 12.7 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
6.3 | 6.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
6.3 | 31.6 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
6.3 | 6.3 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
6.3 | 6.3 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) |
6.3 | 6.3 | GO:0060764 | cell-cell signaling involved in mammary gland development(GO:0060764) |
6.3 | 18.9 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
6.3 | 12.6 | GO:0002654 | regulation of tolerance induction dependent upon immune response(GO:0002652) positive regulation of tolerance induction dependent upon immune response(GO:0002654) |
6.3 | 18.8 | GO:0071284 | cellular response to lead ion(GO:0071284) |
6.3 | 12.5 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
6.3 | 75.1 | GO:0043312 | neutrophil degranulation(GO:0043312) |
6.2 | 24.9 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
6.2 | 31.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
6.2 | 24.8 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
6.2 | 68.1 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
6.2 | 18.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
6.2 | 12.3 | GO:0003162 | atrioventricular node development(GO:0003162) |
6.2 | 12.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
6.1 | 43.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
6.1 | 6.1 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
6.1 | 24.5 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
6.1 | 79.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
6.1 | 54.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
6.1 | 24.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
6.1 | 12.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
6.1 | 84.8 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
6.0 | 18.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
6.0 | 54.0 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
6.0 | 24.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
6.0 | 41.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
5.9 | 29.7 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
5.9 | 17.8 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
5.9 | 53.3 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
5.9 | 23.7 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
5.9 | 23.7 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
5.9 | 23.6 | GO:0002326 | B cell lineage commitment(GO:0002326) |
5.9 | 17.7 | GO:1904585 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) |
5.9 | 5.9 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
5.9 | 93.8 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
5.8 | 23.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
5.8 | 17.5 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
5.8 | 58.2 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
5.8 | 5.8 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
5.8 | 17.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
5.8 | 23.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
5.8 | 28.8 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
5.7 | 17.2 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
5.7 | 11.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
5.7 | 5.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
5.7 | 215.3 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
5.7 | 5.7 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
5.6 | 28.2 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
5.6 | 33.9 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
5.6 | 5.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
5.6 | 50.6 | GO:1902400 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
5.6 | 5.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
5.6 | 16.8 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
5.6 | 16.8 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
5.6 | 55.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
5.6 | 16.7 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
5.6 | 22.3 | GO:1903576 | response to L-arginine(GO:1903576) |
5.6 | 11.1 | GO:0051695 | actin filament uncapping(GO:0051695) |
5.6 | 33.4 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
5.6 | 33.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
5.5 | 27.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
5.5 | 11.1 | GO:0032819 | natural killer cell proliferation(GO:0001787) regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) |
5.5 | 44.0 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
5.5 | 33.0 | GO:0010266 | response to vitamin B1(GO:0010266) |
5.5 | 16.5 | GO:0019417 | sulfur oxidation(GO:0019417) |
5.5 | 54.9 | GO:0006968 | cellular defense response(GO:0006968) |
5.4 | 21.8 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
5.4 | 21.6 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
5.4 | 21.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
5.4 | 21.6 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
5.4 | 32.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
5.4 | 5.4 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
5.4 | 37.7 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
5.4 | 10.8 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
5.4 | 16.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
5.4 | 21.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
5.3 | 15.9 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
5.3 | 21.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
5.3 | 10.5 | GO:2000424 | regulation of eosinophil chemotaxis(GO:2000422) positive regulation of eosinophil chemotaxis(GO:2000424) |
5.3 | 15.8 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
5.2 | 21.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
5.2 | 10.5 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
5.2 | 10.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
5.2 | 10.4 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
5.2 | 5.2 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
5.2 | 67.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
5.1 | 5.1 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
5.1 | 15.4 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
5.1 | 5.1 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
5.1 | 35.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
5.1 | 5.1 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
5.1 | 20.4 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
5.1 | 10.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
5.1 | 15.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
5.1 | 66.0 | GO:0015669 | gas transport(GO:0015669) |
5.0 | 10.1 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
5.0 | 20.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
5.0 | 15.0 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
5.0 | 10.0 | GO:0002934 | desmosome organization(GO:0002934) |
5.0 | 15.0 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
5.0 | 14.9 | GO:2000843 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) |
5.0 | 5.0 | GO:0035627 | ceramide transport(GO:0035627) |
4.9 | 9.9 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
4.9 | 93.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
4.9 | 14.8 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
4.9 | 24.6 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
4.9 | 4.9 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
4.9 | 49.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
4.9 | 24.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
4.9 | 9.8 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
4.9 | 14.6 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
4.8 | 24.2 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
4.8 | 24.1 | GO:0051639 | actin filament network formation(GO:0051639) |
4.8 | 28.9 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
4.8 | 4.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
4.8 | 9.6 | GO:0016240 | autophagosome docking(GO:0016240) |
4.8 | 4.8 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
4.8 | 14.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
4.8 | 14.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
4.8 | 4.8 | GO:1901563 | response to camptothecin(GO:1901563) |
4.8 | 71.6 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
4.8 | 80.9 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
4.8 | 19.0 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
4.8 | 19.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
4.7 | 28.4 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
4.7 | 14.2 | GO:0021569 | rhombomere 3 development(GO:0021569) rhombomere 4 development(GO:0021570) |
4.7 | 61.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
4.7 | 23.5 | GO:0010037 | response to carbon dioxide(GO:0010037) |
4.7 | 4.7 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
4.7 | 32.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
4.7 | 46.9 | GO:0070831 | basement membrane assembly(GO:0070831) |
4.7 | 9.4 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
4.7 | 18.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
4.7 | 27.9 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
4.6 | 13.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
4.6 | 9.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
4.6 | 9.3 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
4.6 | 4.6 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
4.6 | 9.2 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
4.6 | 4.6 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
4.6 | 9.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
4.6 | 32.2 | GO:0090267 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
4.6 | 27.5 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
4.6 | 45.9 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
4.6 | 13.8 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
4.6 | 9.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
4.5 | 13.6 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
4.5 | 13.6 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
4.5 | 45.4 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
4.5 | 31.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
4.5 | 4.5 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
4.5 | 22.7 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
4.5 | 13.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
4.5 | 13.6 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
4.5 | 9.0 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
4.5 | 13.5 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
4.5 | 54.0 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
4.5 | 4.5 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
4.5 | 53.8 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
4.5 | 13.4 | GO:0043587 | tongue morphogenesis(GO:0043587) |
4.5 | 35.8 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
4.5 | 35.8 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
4.5 | 35.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
4.5 | 22.3 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
4.4 | 66.7 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
4.4 | 40.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
4.4 | 4.4 | GO:0015744 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
4.4 | 8.9 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
4.4 | 17.7 | GO:0009992 | cellular water homeostasis(GO:0009992) |
4.4 | 17.7 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
4.4 | 35.3 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
4.4 | 30.9 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
4.4 | 8.8 | GO:0060718 | chorion development(GO:0060717) chorionic trophoblast cell differentiation(GO:0060718) |
4.4 | 70.3 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
4.4 | 153.7 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
4.4 | 17.6 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
4.4 | 8.8 | GO:0071499 | cellular response to laminar fluid shear stress(GO:0071499) |
4.4 | 39.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
4.4 | 17.5 | GO:1904117 | cellular response to vasopressin(GO:1904117) |
4.4 | 69.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
4.4 | 13.1 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
4.4 | 65.4 | GO:0032060 | bleb assembly(GO:0032060) |
4.4 | 26.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
4.4 | 17.4 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
4.4 | 4.4 | GO:0003160 | endocardium morphogenesis(GO:0003160) |
4.3 | 104.3 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
4.3 | 13.0 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
4.3 | 8.7 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
4.3 | 4.3 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
4.3 | 17.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
4.3 | 25.8 | GO:0046208 | spermine catabolic process(GO:0046208) |
4.3 | 21.5 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
4.3 | 12.8 | GO:0001765 | membrane raft assembly(GO:0001765) |
4.3 | 4.3 | GO:0031296 | B cell costimulation(GO:0031296) |
4.3 | 51.3 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
4.2 | 12.7 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
4.2 | 42.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
4.2 | 8.4 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
4.2 | 21.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
4.2 | 12.6 | GO:0034418 | urate biosynthetic process(GO:0034418) |
4.2 | 37.8 | GO:0080009 | mRNA methylation(GO:0080009) |
4.2 | 8.4 | GO:0070295 | renal water absorption(GO:0070295) |
4.2 | 16.8 | GO:0043383 | negative T cell selection(GO:0043383) |
4.2 | 46.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
4.2 | 12.5 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
4.2 | 79.0 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
4.1 | 16.6 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
4.1 | 20.7 | GO:0031529 | ruffle organization(GO:0031529) |
4.1 | 8.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
4.1 | 12.4 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
4.1 | 12.3 | GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
4.1 | 28.8 | GO:0042940 | D-amino acid transport(GO:0042940) |
4.1 | 20.5 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
4.1 | 12.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
4.1 | 12.3 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
4.1 | 8.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
4.1 | 24.5 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
4.1 | 8.2 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
4.1 | 8.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
4.1 | 8.1 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
4.1 | 8.1 | GO:0061010 | gall bladder development(GO:0061010) |
4.1 | 12.2 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
4.0 | 4.0 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
4.0 | 24.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
4.0 | 32.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
4.0 | 44.2 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
4.0 | 12.0 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
4.0 | 36.1 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
4.0 | 4.0 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
4.0 | 4.0 | GO:0021997 | neural plate axis specification(GO:0021997) |
4.0 | 16.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
4.0 | 24.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
4.0 | 8.0 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
4.0 | 11.9 | GO:2000861 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
4.0 | 51.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
4.0 | 19.8 | GO:1901656 | glycoside transport(GO:1901656) |
4.0 | 4.0 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
3.9 | 3.9 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
3.9 | 23.6 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
3.9 | 11.8 | GO:1904976 | cellular response to bleomycin(GO:1904976) |
3.9 | 7.8 | GO:1902568 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
3.9 | 31.3 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
3.9 | 11.7 | GO:1904373 | response to kainic acid(GO:1904373) |
3.9 | 7.8 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
3.9 | 19.4 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
3.9 | 11.6 | GO:0051451 | myoblast migration(GO:0051451) |
3.9 | 11.6 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
3.9 | 30.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
3.8 | 30.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
3.8 | 19.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
3.8 | 19.2 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
3.8 | 65.2 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
3.8 | 11.5 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
3.8 | 30.6 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
3.8 | 15.2 | GO:0051958 | methotrexate transport(GO:0051958) |
3.8 | 11.4 | GO:1902617 | response to fluoride(GO:1902617) |
3.8 | 7.5 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
3.8 | 22.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
3.8 | 7.5 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
3.7 | 18.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
3.7 | 7.5 | GO:0008228 | opsonization(GO:0008228) |
3.7 | 22.5 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
3.7 | 3.7 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
3.7 | 7.5 | GO:0099545 | trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
3.7 | 7.5 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
3.7 | 3.7 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) |
3.7 | 11.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
3.7 | 11.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
3.7 | 51.4 | GO:0035329 | hippo signaling(GO:0035329) |
3.6 | 10.9 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
3.6 | 29.1 | GO:0016266 | O-glycan processing(GO:0016266) |
3.6 | 7.3 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
3.6 | 25.4 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
3.6 | 18.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
3.6 | 3.6 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
3.6 | 10.9 | GO:0017143 | insecticide metabolic process(GO:0017143) |
3.6 | 7.2 | GO:0070839 | divalent metal ion export(GO:0070839) |
3.6 | 14.4 | GO:0071314 | cellular response to cocaine(GO:0071314) |
3.6 | 3.6 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
3.6 | 3.6 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
3.6 | 10.8 | GO:0097350 | neutrophil clearance(GO:0097350) |
3.6 | 43.2 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
3.6 | 14.4 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
3.6 | 10.7 | GO:0015074 | DNA integration(GO:0015074) |
3.6 | 3.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
3.5 | 14.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
3.5 | 60.2 | GO:0050832 | defense response to fungus(GO:0050832) |
3.5 | 10.6 | GO:1903445 | protein transport from ciliary membrane to plasma membrane(GO:1903445) |
3.5 | 24.8 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
3.5 | 28.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
3.5 | 7.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
3.5 | 42.1 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
3.5 | 7.0 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
3.5 | 14.0 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
3.5 | 7.0 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
3.5 | 24.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
3.5 | 17.5 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
3.5 | 7.0 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
3.5 | 10.4 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
3.5 | 24.3 | GO:0051409 | response to nitrosative stress(GO:0051409) |
3.5 | 10.4 | GO:1901228 | negative regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901227) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
3.5 | 10.4 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
3.4 | 10.3 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
3.4 | 51.6 | GO:0050779 | RNA destabilization(GO:0050779) |
3.4 | 37.8 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
3.4 | 10.3 | GO:0046061 | dATP catabolic process(GO:0046061) |
3.4 | 10.3 | GO:0042891 | antibiotic transport(GO:0042891) |
3.4 | 6.8 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
3.4 | 23.9 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
3.4 | 20.5 | GO:0061526 | acetylcholine secretion(GO:0061526) |
3.4 | 44.3 | GO:0070633 | transepithelial transport(GO:0070633) |
3.4 | 10.2 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
3.4 | 10.2 | GO:0010958 | regulation of amino acid import(GO:0010958) |
3.4 | 6.8 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
3.4 | 13.5 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
3.4 | 33.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
3.4 | 13.5 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
3.4 | 40.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
3.4 | 13.4 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
3.4 | 10.1 | GO:0002752 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) cell surface pattern recognition receptor signaling pathway(GO:0002752) |
3.4 | 16.8 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
3.3 | 10.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
3.3 | 116.7 | GO:0070527 | platelet aggregation(GO:0070527) |
3.3 | 13.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
3.3 | 39.9 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
3.3 | 19.9 | GO:0036336 | dendritic cell migration(GO:0036336) |
3.3 | 36.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
3.3 | 9.9 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
3.3 | 9.9 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
3.3 | 6.6 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
3.3 | 6.6 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
3.3 | 13.2 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
3.3 | 6.5 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
3.3 | 13.0 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
3.3 | 3.3 | GO:0036023 | embryonic skeletal limb joint morphogenesis(GO:0036023) |
3.3 | 13.0 | GO:1904587 | response to glycoprotein(GO:1904587) |
3.3 | 81.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
3.3 | 19.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
3.2 | 6.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
3.2 | 45.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
3.2 | 22.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
3.2 | 22.3 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
3.2 | 9.6 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
3.2 | 73.2 | GO:0030033 | microvillus assembly(GO:0030033) |
3.2 | 15.8 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
3.2 | 28.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
3.2 | 22.1 | GO:0035878 | nail development(GO:0035878) |
3.2 | 3.2 | GO:1990478 | response to ultrasound(GO:1990478) |
3.1 | 12.5 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
3.1 | 9.4 | GO:0051414 | response to cortisol(GO:0051414) |
3.1 | 9.3 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
3.1 | 12.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
3.1 | 28.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
3.1 | 12.4 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
3.1 | 6.2 | GO:0034312 | diol biosynthetic process(GO:0034312) |
3.1 | 31.0 | GO:0006265 | DNA topological change(GO:0006265) |
3.1 | 58.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
3.1 | 6.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
3.1 | 12.4 | GO:0072313 | metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
3.1 | 9.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
3.1 | 21.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
3.1 | 9.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
3.1 | 6.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
3.1 | 6.1 | GO:0009751 | response to salicylic acid(GO:0009751) |
3.1 | 27.5 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
3.1 | 24.4 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
3.1 | 6.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
3.1 | 39.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
3.1 | 24.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
3.0 | 6.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
3.0 | 21.2 | GO:0060056 | mammary gland involution(GO:0060056) |
3.0 | 36.3 | GO:0090023 | positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
3.0 | 3.0 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
3.0 | 33.2 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
3.0 | 6.0 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
3.0 | 6.0 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
3.0 | 6.0 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
3.0 | 32.9 | GO:1902041 | regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902041) |
3.0 | 14.9 | GO:0050828 | regulation of liquid surface tension(GO:0050828) |
3.0 | 17.9 | GO:0032494 | response to peptidoglycan(GO:0032494) |
3.0 | 8.9 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
3.0 | 8.9 | GO:0097298 | regulation of nucleus size(GO:0097298) |
3.0 | 11.9 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
3.0 | 23.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
3.0 | 38.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
3.0 | 14.8 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
3.0 | 8.9 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
3.0 | 5.9 | GO:0048143 | astrocyte activation(GO:0048143) |
3.0 | 17.7 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
3.0 | 3.0 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
2.9 | 11.8 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
2.9 | 32.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
2.9 | 8.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.9 | 23.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
2.9 | 2.9 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
2.9 | 20.4 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
2.9 | 5.8 | GO:0034145 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
2.9 | 8.7 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
2.9 | 17.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
2.9 | 14.5 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
2.9 | 5.8 | GO:0000050 | urea cycle(GO:0000050) |
2.9 | 43.5 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
2.9 | 11.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
2.9 | 20.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
2.9 | 20.2 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
2.9 | 8.6 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
2.9 | 31.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
2.9 | 11.5 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
2.9 | 14.3 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
2.9 | 5.7 | GO:1904732 | regulation of electron carrier activity(GO:1904732) |
2.8 | 11.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
2.8 | 48.0 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
2.8 | 5.6 | GO:0006738 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
2.8 | 28.2 | GO:0060544 | regulation of necroptotic process(GO:0060544) |
2.8 | 11.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
2.8 | 8.3 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
2.8 | 5.6 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
2.8 | 27.7 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) |
2.8 | 8.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
2.8 | 19.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
2.8 | 16.5 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
2.7 | 2.7 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
2.7 | 8.2 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
2.7 | 21.9 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
2.7 | 8.1 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
2.7 | 19.0 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
2.7 | 21.6 | GO:0043129 | surfactant homeostasis(GO:0043129) |
2.7 | 8.1 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
2.7 | 13.4 | GO:0030421 | defecation(GO:0030421) |
2.7 | 18.6 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
2.7 | 45.1 | GO:0006783 | heme biosynthetic process(GO:0006783) |
2.6 | 5.3 | GO:0070268 | cornification(GO:0070268) |
2.6 | 87.4 | GO:0097202 | activation of cysteine-type endopeptidase activity(GO:0097202) |
2.6 | 2.6 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
2.6 | 34.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
2.6 | 5.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
2.6 | 5.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
2.6 | 7.8 | GO:0036394 | amylase secretion(GO:0036394) |
2.6 | 28.6 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
2.6 | 10.4 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
2.6 | 10.3 | GO:0046514 | ceramide catabolic process(GO:0046514) |
2.6 | 12.9 | GO:0060896 | neural plate anterior/posterior regionalization(GO:0021999) neural plate pattern specification(GO:0060896) neural plate regionalization(GO:0060897) |
2.6 | 7.7 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
2.6 | 7.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
2.6 | 18.0 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
2.6 | 5.1 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
2.6 | 12.8 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
2.5 | 15.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
2.5 | 48.0 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
2.5 | 50.4 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
2.5 | 68.0 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
2.5 | 7.5 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
2.5 | 5.0 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
2.5 | 9.9 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
2.5 | 12.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
2.5 | 12.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
2.5 | 2.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
2.5 | 2.5 | GO:0061009 | common bile duct development(GO:0061009) |
2.5 | 14.7 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
2.5 | 7.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
2.5 | 17.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
2.5 | 4.9 | GO:1902336 | positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
2.5 | 2.5 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
2.4 | 7.3 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
2.4 | 12.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
2.4 | 26.8 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
2.4 | 17.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
2.4 | 59.9 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
2.4 | 9.6 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
2.4 | 4.8 | GO:0000212 | meiotic spindle organization(GO:0000212) |
2.4 | 11.9 | GO:0048539 | bone marrow development(GO:0048539) |
2.4 | 11.8 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
2.4 | 11.8 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
2.4 | 11.8 | GO:0045738 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
2.3 | 14.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
2.3 | 18.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
2.3 | 9.3 | GO:0031179 | peptide modification(GO:0031179) |
2.3 | 39.5 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
2.3 | 25.5 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
2.3 | 2.3 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
2.3 | 2.3 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
2.3 | 13.8 | GO:0034063 | stress granule assembly(GO:0034063) |
2.3 | 13.8 | GO:0051255 | spindle midzone assembly(GO:0051255) |
2.3 | 62.1 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
2.3 | 6.9 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
2.3 | 6.9 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
2.3 | 22.9 | GO:0048255 | mRNA stabilization(GO:0048255) |
2.3 | 9.1 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
2.3 | 11.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
2.3 | 2.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
2.2 | 31.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
2.2 | 6.7 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
2.2 | 15.6 | GO:0035646 | endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
2.2 | 20.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
2.2 | 4.5 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
2.2 | 8.9 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
2.2 | 6.7 | GO:0008358 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
2.2 | 6.7 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
2.2 | 8.9 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
2.2 | 40.0 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
2.2 | 11.1 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
2.2 | 2.2 | GO:0034239 | regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
2.2 | 26.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
2.2 | 55.2 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
2.2 | 19.9 | GO:0070166 | enamel mineralization(GO:0070166) |
2.2 | 15.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
2.2 | 2.2 | GO:0010182 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
2.2 | 41.5 | GO:0010165 | response to X-ray(GO:0010165) |
2.2 | 4.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
2.2 | 6.5 | GO:0071671 | regulation of smooth muscle cell chemotaxis(GO:0071671) |
2.2 | 2.2 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
2.2 | 15.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
2.2 | 32.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
2.2 | 10.8 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
2.2 | 12.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
2.2 | 12.9 | GO:0015705 | iodide transport(GO:0015705) |
2.2 | 19.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
2.1 | 4.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
2.1 | 8.5 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
2.1 | 8.5 | GO:0090131 | mesenchyme migration(GO:0090131) |
2.1 | 25.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
2.1 | 21.3 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
2.1 | 4.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
2.1 | 6.4 | GO:0003383 | apical constriction(GO:0003383) |
2.1 | 12.7 | GO:0043297 | apical junction assembly(GO:0043297) |
2.1 | 14.8 | GO:0070914 | UV-damage excision repair(GO:0070914) |
2.1 | 6.3 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
2.1 | 12.6 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
2.1 | 21.0 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
2.1 | 4.2 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
2.1 | 2.1 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
2.1 | 18.7 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
2.1 | 4.1 | GO:0021558 | noradrenergic neuron differentiation(GO:0003357) trochlear nerve development(GO:0021558) |
2.1 | 28.9 | GO:0031297 | replication fork processing(GO:0031297) |
2.1 | 4.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
2.1 | 20.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
2.1 | 12.3 | GO:0033260 | nuclear DNA replication(GO:0033260) |
2.1 | 51.3 | GO:0060325 | face morphogenesis(GO:0060325) |
2.1 | 8.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
2.0 | 4.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
2.0 | 2.0 | GO:0002158 | osteoclast proliferation(GO:0002158) |
2.0 | 8.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
2.0 | 28.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
2.0 | 22.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
2.0 | 14.1 | GO:0045089 | positive regulation of innate immune response(GO:0045089) |
2.0 | 20.1 | GO:0051601 | exocyst localization(GO:0051601) |
2.0 | 10.0 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
2.0 | 4.0 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
2.0 | 17.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
2.0 | 6.0 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
2.0 | 9.9 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
2.0 | 5.9 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
2.0 | 7.9 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
2.0 | 2.0 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
2.0 | 7.9 | GO:0044691 | tooth eruption(GO:0044691) |
2.0 | 5.9 | GO:0006517 | protein deglycosylation(GO:0006517) |
2.0 | 2.0 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
2.0 | 9.8 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
2.0 | 19.6 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
1.9 | 5.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.9 | 60.2 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
1.9 | 11.6 | GO:0046836 | glycolipid transport(GO:0046836) |
1.9 | 15.5 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
1.9 | 9.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
1.9 | 25.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
1.9 | 9.6 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
1.9 | 13.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
1.9 | 21.1 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
1.9 | 30.6 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
1.9 | 53.5 | GO:0001706 | endoderm formation(GO:0001706) |
1.9 | 5.7 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.9 | 11.4 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
1.9 | 3.8 | GO:0021564 | vagus nerve development(GO:0021564) |
1.9 | 7.6 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
1.9 | 5.7 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
1.9 | 3.8 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
1.9 | 9.4 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
1.9 | 5.6 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
1.9 | 16.8 | GO:0017121 | phospholipid scrambling(GO:0017121) |
1.9 | 1.9 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
1.9 | 1.9 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
1.9 | 5.6 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
1.9 | 3.7 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
1.9 | 9.3 | GO:0001842 | neural fold formation(GO:0001842) |
1.9 | 7.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
1.9 | 35.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
1.9 | 18.6 | GO:0015732 | prostaglandin transport(GO:0015732) |
1.9 | 13.0 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
1.8 | 11.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.8 | 1.8 | GO:1990868 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
1.8 | 25.8 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
1.8 | 5.5 | GO:0072053 | renal inner medulla development(GO:0072053) |
1.8 | 25.7 | GO:0090382 | phagosome maturation(GO:0090382) |
1.8 | 7.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.8 | 64.0 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) |
1.8 | 1.8 | GO:1904884 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
1.8 | 1.8 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
1.8 | 5.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
1.8 | 29.0 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
1.8 | 1.8 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) positive regulation of histone phosphorylation(GO:0033129) |
1.8 | 34.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
1.8 | 7.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
1.8 | 16.2 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
1.8 | 3.6 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
1.8 | 3.6 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.8 | 14.4 | GO:0070307 | lens fiber cell development(GO:0070307) |
1.8 | 19.7 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
1.8 | 7.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
1.8 | 3.5 | GO:0060003 | copper ion export(GO:0060003) |
1.8 | 14.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.8 | 3.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
1.8 | 12.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.8 | 3.5 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
1.8 | 7.0 | GO:0019985 | translesion synthesis(GO:0019985) |
1.7 | 14.0 | GO:0043584 | nose development(GO:0043584) |
1.7 | 1.7 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
1.7 | 10.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.7 | 19.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
1.7 | 6.9 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.7 | 5.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.7 | 74.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
1.7 | 1.7 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
1.7 | 8.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.7 | 1.7 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
1.7 | 12.0 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
1.7 | 1.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.7 | 10.2 | GO:0032365 | intracellular lipid transport(GO:0032365) |
1.7 | 11.8 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
1.7 | 1.7 | GO:0061140 | lung secretory cell differentiation(GO:0061140) |
1.7 | 1.7 | GO:0042196 | chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
1.7 | 6.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.7 | 5.0 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
1.7 | 10.0 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
1.7 | 10.0 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.7 | 8.3 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
1.7 | 26.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
1.7 | 5.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
1.7 | 14.9 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
1.7 | 3.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
1.7 | 14.9 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
1.7 | 24.8 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
1.7 | 38.0 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
1.6 | 9.9 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
1.6 | 1.6 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
1.6 | 1.6 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
1.6 | 11.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.6 | 3.3 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
1.6 | 1.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.6 | 3.2 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
1.6 | 17.8 | GO:0070986 | left/right axis specification(GO:0070986) |
1.6 | 3.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
1.6 | 29.0 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
1.6 | 3.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
1.6 | 8.0 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
1.6 | 4.8 | GO:1903566 | ciliary basal body organization(GO:0032053) positive regulation of protein localization to cilium(GO:1903566) |
1.6 | 16.0 | GO:0048536 | spleen development(GO:0048536) |
1.6 | 8.0 | GO:0000303 | response to superoxide(GO:0000303) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
1.6 | 14.4 | GO:0032274 | gonadotropin secretion(GO:0032274) |
1.6 | 19.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
1.6 | 15.9 | GO:0048538 | thymus development(GO:0048538) |
1.6 | 6.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.6 | 3.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
1.6 | 1.6 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
1.6 | 6.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
1.6 | 4.7 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
1.6 | 14.0 | GO:0036065 | fucosylation(GO:0036065) |
1.5 | 1.5 | GO:0046607 | positive regulation of centrosome duplication(GO:0010825) positive regulation of centrosome cycle(GO:0046607) |
1.5 | 15.4 | GO:0042044 | fluid transport(GO:0042044) |
1.5 | 1.5 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
1.5 | 16.9 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
1.5 | 7.7 | GO:0042256 | mature ribosome assembly(GO:0042256) |
1.5 | 4.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
1.5 | 12.3 | GO:0015886 | heme transport(GO:0015886) |
1.5 | 6.2 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
1.5 | 24.6 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
1.5 | 6.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
1.5 | 4.6 | GO:0034405 | response to fluid shear stress(GO:0034405) |
1.5 | 12.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.5 | 16.7 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
1.5 | 4.5 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
1.5 | 1.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
1.5 | 3.0 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
1.5 | 4.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.5 | 6.0 | GO:1904401 | response to Thyroid stimulating hormone(GO:1904400) cellular response to Thyroid stimulating hormone(GO:1904401) |
1.5 | 21.0 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
1.5 | 18.0 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
1.5 | 4.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
1.5 | 4.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
1.5 | 5.9 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
1.5 | 11.8 | GO:0015825 | L-serine transport(GO:0015825) |
1.5 | 2.9 | GO:0032258 | CVT pathway(GO:0032258) |
1.5 | 2.9 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
1.5 | 4.4 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
1.5 | 14.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
1.4 | 2.9 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
1.4 | 7.2 | GO:0032439 | endosome localization(GO:0032439) |
1.4 | 21.4 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
1.4 | 5.7 | GO:0032571 | response to vitamin K(GO:0032571) |
1.4 | 1.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
1.4 | 7.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.4 | 53.4 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
1.4 | 5.6 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
1.4 | 5.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
1.4 | 4.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
1.4 | 19.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
1.4 | 5.5 | GO:0031268 | pseudopodium organization(GO:0031268) |
1.4 | 9.6 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
1.4 | 20.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
1.4 | 10.9 | GO:0051310 | metaphase plate congression(GO:0051310) |
1.4 | 16.3 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
1.4 | 2.7 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
1.4 | 4.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
1.4 | 16.3 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
1.4 | 2.7 | GO:0043489 | RNA stabilization(GO:0043489) |
1.4 | 29.8 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
1.4 | 4.1 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
1.4 | 12.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.3 | 16.1 | GO:0035634 | response to stilbenoid(GO:0035634) |
1.3 | 8.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
1.3 | 2.7 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
1.3 | 4.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.3 | 26.6 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
1.3 | 4.0 | GO:0044209 | AMP salvage(GO:0044209) |
1.3 | 9.3 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
1.3 | 10.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.3 | 14.6 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
1.3 | 54.1 | GO:0006302 | double-strand break repair(GO:0006302) |
1.3 | 7.9 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
1.3 | 1.3 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.3 | 9.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
1.3 | 3.9 | GO:0019348 | dolichol metabolic process(GO:0019348) |
1.3 | 1.3 | GO:0045682 | regulation of epidermis development(GO:0045682) |
1.3 | 2.6 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
1.3 | 2.6 | GO:0080144 | amino acid homeostasis(GO:0080144) |
1.3 | 41.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
1.3 | 3.8 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
1.3 | 12.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
1.3 | 6.4 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
1.3 | 3.8 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.3 | 20.4 | GO:0006855 | drug transmembrane transport(GO:0006855) |
1.3 | 3.8 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
1.3 | 1.3 | GO:0061741 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) |
1.3 | 15.2 | GO:0030851 | granulocyte differentiation(GO:0030851) |
1.3 | 25.3 | GO:0031648 | protein destabilization(GO:0031648) |
1.3 | 11.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.3 | 5.0 | GO:0006907 | pinocytosis(GO:0006907) |
1.3 | 23.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
1.3 | 53.9 | GO:0051225 | spindle assembly(GO:0051225) |
1.3 | 2.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
1.3 | 5.0 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
1.2 | 2.5 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
1.2 | 2.5 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
1.2 | 6.1 | GO:1905214 | regulation of RNA binding(GO:1905214) |
1.2 | 7.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
1.2 | 9.8 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
1.2 | 2.4 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
1.2 | 6.1 | GO:0010586 | miRNA metabolic process(GO:0010586) |
1.2 | 25.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
1.2 | 1.2 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.2 | 10.9 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
1.2 | 7.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.2 | 2.4 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
1.2 | 2.4 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.2 | 2.4 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
1.2 | 3.6 | GO:0036491 | regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
1.2 | 21.4 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
1.2 | 2.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.2 | 38.6 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
1.2 | 8.2 | GO:1990403 | embryonic brain development(GO:1990403) |
1.2 | 8.2 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
1.2 | 4.6 | GO:0044211 | CTP salvage(GO:0044211) |
1.2 | 2.3 | GO:0016078 | tRNA catabolic process(GO:0016078) |
1.2 | 2.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.2 | 23.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
1.2 | 5.8 | GO:0086047 | Purkinje myocyte action potential(GO:0086017) membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
1.2 | 8.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
1.2 | 18.5 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
1.2 | 1.2 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
1.1 | 18.4 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
1.1 | 2.3 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
1.1 | 22.9 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
1.1 | 3.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
1.1 | 4.5 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
1.1 | 2.3 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
1.1 | 2.3 | GO:0070375 | ERK5 cascade(GO:0070375) |
1.1 | 2.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.1 | 2.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.1 | 3.4 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
1.1 | 51.3 | GO:0002757 | immune response-activating signal transduction(GO:0002757) |
1.1 | 2.2 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
1.1 | 2.2 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
1.1 | 5.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
1.1 | 1.1 | GO:0048102 | autophagic cell death(GO:0048102) |
1.1 | 3.3 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
1.1 | 6.5 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
1.1 | 3.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
1.1 | 5.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
1.1 | 3.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.1 | 4.3 | GO:0015811 | L-cystine transport(GO:0015811) |
1.1 | 19.2 | GO:0019882 | antigen processing and presentation(GO:0019882) |
1.1 | 9.6 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
1.1 | 86.1 | GO:0008360 | regulation of cell shape(GO:0008360) |
1.1 | 50.9 | GO:0000819 | sister chromatid segregation(GO:0000819) |
1.1 | 2.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
1.1 | 5.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
1.0 | 3.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.0 | 1.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.0 | 3.1 | GO:0022616 | DNA strand elongation(GO:0022616) |
1.0 | 2.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.0 | 2.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.0 | 2.0 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
1.0 | 2.0 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
1.0 | 2.0 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
1.0 | 4.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
1.0 | 3.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.0 | 25.3 | GO:0030032 | lamellipodium assembly(GO:0030032) |
1.0 | 8.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
1.0 | 1.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.0 | 15.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.0 | 8.9 | GO:0035608 | protein deglutamylation(GO:0035608) |
1.0 | 6.9 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
1.0 | 8.8 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
1.0 | 21.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
1.0 | 13.5 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
1.0 | 43.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
1.0 | 4.8 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
1.0 | 1.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.9 | 4.7 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.9 | 2.8 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.9 | 22.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.9 | 2.8 | GO:0032218 | riboflavin transport(GO:0032218) |
0.9 | 3.8 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.9 | 5.6 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.9 | 6.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.9 | 56.6 | GO:0051607 | defense response to virus(GO:0051607) |
0.9 | 1.8 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.9 | 7.4 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.9 | 0.9 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.9 | 2.7 | GO:1903232 | melanosome assembly(GO:1903232) |
0.9 | 5.5 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.9 | 3.6 | GO:0060699 | regulation of endoribonuclease activity(GO:0060699) |
0.9 | 11.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.9 | 6.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.9 | 3.6 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.9 | 3.6 | GO:0042730 | fibrinolysis(GO:0042730) |
0.9 | 1.8 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.9 | 0.9 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.9 | 3.5 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.9 | 3.5 | GO:0045428 | regulation of nitric oxide biosynthetic process(GO:0045428) |
0.9 | 6.1 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.9 | 2.6 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.9 | 0.9 | GO:1903301 | regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.8 | 2.5 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.8 | 9.3 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.8 | 0.8 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.8 | 3.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.8 | 0.8 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.8 | 3.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.8 | 19.9 | GO:0030217 | T cell differentiation(GO:0030217) |
0.8 | 12.4 | GO:0051028 | mRNA transport(GO:0051028) |
0.8 | 17.4 | GO:0001824 | blastocyst development(GO:0001824) |
0.8 | 6.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.8 | 10.7 | GO:0006284 | base-excision repair(GO:0006284) |
0.8 | 1.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.8 | 6.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.8 | 8.0 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.8 | 3.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.8 | 3.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.8 | 3.9 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.8 | 0.8 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) negative regulation of protein deubiquitination(GO:0090086) |
0.8 | 7.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.8 | 7.0 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.8 | 1.6 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
0.8 | 2.3 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.8 | 5.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.8 | 6.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.8 | 3.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.8 | 1.5 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.8 | 6.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.8 | 1.5 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.8 | 0.8 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.8 | 1.5 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.8 | 1.5 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
0.8 | 0.8 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.8 | 2.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.8 | 9.1 | GO:0045766 | positive regulation of angiogenesis(GO:0045766) |
0.7 | 4.5 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.7 | 3.0 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.7 | 3.7 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.7 | 8.9 | GO:0030183 | B cell differentiation(GO:0030183) |
0.7 | 3.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.7 | 5.9 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.7 | 8.8 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.7 | 3.6 | GO:0042119 | neutrophil activation(GO:0042119) |
0.7 | 6.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.7 | 1.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.7 | 2.9 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.7 | 12.1 | GO:0035904 | aorta development(GO:0035904) |
0.7 | 4.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.7 | 4.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.7 | 3.5 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.7 | 17.1 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
0.7 | 3.4 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.7 | 4.7 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.7 | 3.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.7 | 3.3 | GO:0006842 | tricarboxylic acid transport(GO:0006842) |
0.7 | 10.5 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.7 | 2.6 | GO:0010324 | membrane invagination(GO:0010324) |
0.6 | 3.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.6 | 2.6 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.6 | 1.9 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.6 | 3.9 | GO:0033561 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
0.6 | 3.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.6 | 1.9 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.6 | 10.0 | GO:0015858 | nucleoside transport(GO:0015858) |
0.6 | 1.2 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.6 | 2.5 | GO:0042092 | type 2 immune response(GO:0042092) |
0.6 | 1.8 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.6 | 9.7 | GO:0007032 | endosome organization(GO:0007032) |
0.6 | 1.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.6 | 1.8 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.6 | 1.2 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.6 | 1.7 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.6 | 4.6 | GO:0009651 | response to salt stress(GO:0009651) |
0.6 | 0.6 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.6 | 1.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.6 | 1.7 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.6 | 7.9 | GO:0046782 | regulation of viral transcription(GO:0046782) |
0.6 | 0.6 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.6 | 1.7 | GO:0070918 | dsRNA fragmentation(GO:0031050) production of small RNA involved in gene silencing by RNA(GO:0070918) |
0.6 | 1.7 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.6 | 2.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.6 | 2.8 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.5 | 4.9 | GO:0060425 | lung morphogenesis(GO:0060425) |
0.5 | 3.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.5 | 189.0 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.5 | 0.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.5 | 11.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.5 | 13.1 | GO:0007569 | cell aging(GO:0007569) |
0.5 | 1.0 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.5 | 2.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.5 | 7.7 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.5 | 0.5 | GO:0070231 | T cell apoptotic process(GO:0070231) |
0.5 | 7.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.5 | 0.5 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.5 | 1.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.5 | 1.5 | GO:0016598 | protein arginylation(GO:0016598) |
0.5 | 1.5 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.5 | 2.5 | GO:0060539 | diaphragm development(GO:0060539) |
0.5 | 5.0 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.5 | 5.4 | GO:0051875 | melanosome localization(GO:0032400) pigment granule localization(GO:0051875) |
0.5 | 4.4 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.5 | 1.5 | GO:0043387 | toxin catabolic process(GO:0009407) mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) secondary metabolite catabolic process(GO:0090487) organic heteropentacyclic compound catabolic process(GO:1901377) |
0.5 | 0.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.5 | 15.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.5 | 2.9 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.5 | 1.9 | GO:0097332 | response to antipsychotic drug(GO:0097332) |
0.5 | 15.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.5 | 4.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.5 | 2.8 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.5 | 4.1 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.5 | 0.9 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.4 | 1.8 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.4 | 0.9 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
0.4 | 3.1 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.4 | 8.4 | GO:0097503 | sialylation(GO:0097503) |
0.4 | 3.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.4 | 2.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.4 | 5.6 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.4 | 5.1 | GO:0009303 | rRNA transcription(GO:0009303) |
0.4 | 4.5 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.4 | 2.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.4 | 6.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.4 | 4.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.4 | 1.2 | GO:0030903 | notochord development(GO:0030903) |
0.4 | 11.3 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.4 | 5.2 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.4 | 6.8 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.4 | 1.6 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.4 | 0.8 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.4 | 1.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.4 | 0.8 | GO:2000078 | positive regulation of type B pancreatic cell development(GO:2000078) |
0.4 | 1.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 3.5 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.4 | 8.8 | GO:0030488 | tRNA methylation(GO:0030488) |
0.4 | 3.4 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.4 | 2.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.4 | 1.9 | GO:0030098 | lymphocyte differentiation(GO:0030098) |
0.4 | 1.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.4 | 6.2 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.4 | 2.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 1.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.4 | 0.7 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.4 | 1.4 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.3 | 0.7 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 7.7 | GO:0002250 | adaptive immune response(GO:0002250) |
0.3 | 4.0 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.3 | 0.3 | GO:1901073 | N-acetylglucosamine biosynthetic process(GO:0006045) N-acetylneuraminate biosynthetic process(GO:0046380) glucosamine-containing compound biosynthetic process(GO:1901073) |
0.3 | 2.2 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.3 | 1.6 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.3 | 0.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.3 | 1.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 0.6 | GO:1902893 | regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902893) |
0.3 | 4.9 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.3 | 0.8 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.3 | 1.6 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
0.3 | 3.2 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.3 | 2.9 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.3 | 0.8 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.3 | 0.8 | GO:1903413 | cellular response to bile acid(GO:1903413) |
0.3 | 1.0 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.3 | 1.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.3 | 1.8 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.2 | 1.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 0.2 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.2 | 1.2 | GO:0001554 | luteolysis(GO:0001554) |
0.2 | 0.7 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.2 | 1.0 | GO:0031295 | T cell costimulation(GO:0031295) |
0.2 | 0.9 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 0.7 | GO:0033504 | floor plate development(GO:0033504) |
0.2 | 0.7 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.2 | 0.4 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.2 | 2.2 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.2 | 0.2 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.2 | 0.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.2 | 29.8 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.2 | 2.3 | GO:0006959 | humoral immune response(GO:0006959) |
0.2 | 1.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.2 | 1.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 0.6 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 1.8 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 4.8 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.2 | 3.6 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.2 | 1.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 0.7 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.2 | 1.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.5 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.2 | 0.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.2 | 0.5 | GO:0060290 | transdifferentiation(GO:0060290) |
0.2 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 3.0 | GO:0001841 | neural tube formation(GO:0001841) |
0.1 | 0.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.8 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.1 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.9 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 6.5 | GO:0006260 | DNA replication(GO:0006260) |
0.1 | 0.1 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
0.1 | 0.5 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 1.4 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.1 | 0.6 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.4 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.3 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.5 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.1 | 0.4 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.1 | 0.5 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 1.0 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.1 | 1.0 | GO:0008272 | sulfate transport(GO:0008272) sulfate transmembrane transport(GO:1902358) |
0.1 | 1.6 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 1.2 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 2.5 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.6 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 1.9 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) negative regulation of binding of sperm to zona pellucida(GO:2000360) |
0.1 | 0.5 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.1 | 0.4 | GO:0001935 | endothelial cell proliferation(GO:0001935) |
0.1 | 0.3 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.1 | 0.2 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.0 | 0.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 0.3 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.0 | GO:0072422 | signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
27.6 | 110.4 | GO:0044393 | microspike(GO:0044393) |
22.1 | 66.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
21.8 | 65.5 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
18.4 | 165.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
16.5 | 131.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
16.3 | 65.1 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
14.3 | 57.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
13.8 | 41.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
13.5 | 40.6 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
13.4 | 107.1 | GO:0000796 | condensin complex(GO:0000796) |
13.1 | 78.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
12.7 | 50.9 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
12.6 | 37.8 | GO:0097651 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
12.3 | 98.3 | GO:0097443 | sorting endosome(GO:0097443) |
11.9 | 23.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
11.9 | 47.4 | GO:0005607 | laminin-2 complex(GO:0005607) |
11.6 | 34.9 | GO:0032398 | MHC class Ib protein complex(GO:0032398) |
11.6 | 11.6 | GO:0045298 | tubulin complex(GO:0045298) |
11.1 | 55.7 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
11.1 | 33.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
10.9 | 141.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
10.7 | 32.2 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
10.6 | 74.0 | GO:1990357 | terminal web(GO:1990357) |
10.6 | 52.8 | GO:0071953 | elastic fiber(GO:0071953) |
10.4 | 10.4 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
10.3 | 41.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
10.1 | 30.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
10.1 | 80.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
10.1 | 40.3 | GO:0097427 | microtubule bundle(GO:0097427) |
9.7 | 77.4 | GO:0070820 | tertiary granule(GO:0070820) |
9.5 | 66.6 | GO:0060205 | cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
9.5 | 122.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
9.4 | 37.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
9.4 | 65.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
9.3 | 28.0 | GO:0000811 | GINS complex(GO:0000811) |
9.0 | 35.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
8.8 | 44.2 | GO:0043293 | apoptosome(GO:0043293) |
8.8 | 26.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
8.6 | 85.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
8.0 | 24.1 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
7.9 | 134.9 | GO:0070938 | contractile ring(GO:0070938) |
7.7 | 30.6 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
7.6 | 53.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
7.6 | 98.9 | GO:0031143 | pseudopodium(GO:0031143) |
7.6 | 30.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
7.6 | 75.8 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
7.5 | 37.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
7.4 | 141.4 | GO:0030057 | desmosome(GO:0030057) |
7.3 | 21.9 | GO:0032173 | septin collar(GO:0032173) |
7.2 | 50.6 | GO:0042825 | TAP complex(GO:0042825) |
7.1 | 21.2 | GO:1990423 | RZZ complex(GO:1990423) |
7.0 | 98.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
6.9 | 6.9 | GO:1990826 | nucleoplasmic periphery of the nuclear pore complex(GO:1990826) |
6.6 | 19.9 | GO:0035101 | FACT complex(GO:0035101) |
6.6 | 13.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
6.5 | 38.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
6.4 | 19.2 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
6.4 | 185.7 | GO:0008305 | integrin complex(GO:0008305) |
6.3 | 19.0 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
6.3 | 44.2 | GO:0090543 | Flemming body(GO:0090543) |
6.2 | 24.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
6.1 | 67.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
6.0 | 6.0 | GO:0035577 | azurophil granule membrane(GO:0035577) |
6.0 | 36.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
5.9 | 71.0 | GO:0071564 | npBAF complex(GO:0071564) |
5.8 | 519.7 | GO:0032432 | actin filament bundle(GO:0032432) |
5.8 | 29.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
5.7 | 39.7 | GO:0001651 | dense fibrillar component(GO:0001651) |
5.6 | 112.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
5.6 | 61.5 | GO:0016600 | flotillin complex(GO:0016600) |
5.6 | 44.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
5.5 | 33.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
5.5 | 104.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
5.5 | 70.9 | GO:0016580 | Sin3 complex(GO:0016580) |
5.3 | 21.3 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
5.3 | 5.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
5.2 | 31.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
5.2 | 20.6 | GO:0070876 | SOSS complex(GO:0070876) |
5.1 | 46.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
5.1 | 35.7 | GO:0031983 | vesicle lumen(GO:0031983) |
5.1 | 30.5 | GO:0036396 | MIS complex(GO:0036396) |
5.1 | 15.3 | GO:0001740 | Barr body(GO:0001740) |
5.0 | 90.5 | GO:0032433 | filopodium tip(GO:0032433) |
5.0 | 39.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
4.9 | 24.7 | GO:0031085 | BLOC-3 complex(GO:0031085) |
4.9 | 4.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
4.9 | 14.6 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
4.8 | 43.5 | GO:0042555 | MCM complex(GO:0042555) |
4.8 | 19.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
4.8 | 38.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
4.8 | 128.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
4.8 | 28.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
4.8 | 33.3 | GO:0071203 | WASH complex(GO:0071203) |
4.7 | 9.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
4.7 | 9.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
4.7 | 79.4 | GO:0031528 | microvillus membrane(GO:0031528) |
4.7 | 153.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
4.6 | 9.3 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
4.6 | 27.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
4.6 | 22.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
4.5 | 127.4 | GO:0042588 | zymogen granule(GO:0042588) |
4.5 | 18.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
4.5 | 49.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
4.4 | 17.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
4.3 | 112.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
4.3 | 12.9 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
4.3 | 29.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
4.3 | 29.8 | GO:0042382 | paraspeckles(GO:0042382) |
4.2 | 66.9 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
4.2 | 12.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
4.2 | 8.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
4.2 | 199.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
4.1 | 29.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
4.1 | 12.4 | GO:0070826 | paraferritin complex(GO:0070826) |
4.1 | 4.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
4.0 | 20.2 | GO:0030478 | actin cap(GO:0030478) |
4.0 | 12.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
4.0 | 4.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
4.0 | 32.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
4.0 | 19.9 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
4.0 | 31.6 | GO:0032009 | early phagosome(GO:0032009) |
3.9 | 27.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
3.9 | 50.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
3.8 | 26.8 | GO:0001940 | male pronucleus(GO:0001940) |
3.8 | 11.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
3.8 | 30.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
3.8 | 15.0 | GO:0035363 | histone locus body(GO:0035363) |
3.8 | 22.5 | GO:0031209 | SCAR complex(GO:0031209) |
3.7 | 18.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
3.7 | 7.4 | GO:0000974 | Prp19 complex(GO:0000974) |
3.7 | 11.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
3.7 | 11.1 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
3.7 | 18.5 | GO:0016342 | catenin complex(GO:0016342) |
3.7 | 33.1 | GO:0045179 | apical cortex(GO:0045179) |
3.6 | 3.6 | GO:0044609 | DBIRD complex(GO:0044609) |
3.6 | 32.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
3.5 | 27.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
3.4 | 24.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
3.4 | 17.1 | GO:0034455 | t-UTP complex(GO:0034455) |
3.4 | 10.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
3.4 | 3.4 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
3.4 | 16.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
3.4 | 84.2 | GO:0001772 | immunological synapse(GO:0001772) |
3.4 | 70.4 | GO:0002102 | podosome(GO:0002102) |
3.3 | 13.3 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
3.3 | 6.6 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
3.3 | 46.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
3.3 | 71.8 | GO:0001891 | phagocytic cup(GO:0001891) |
3.2 | 1239.9 | GO:0005925 | focal adhesion(GO:0005925) |
3.2 | 12.8 | GO:0097422 | tubular endosome(GO:0097422) |
3.2 | 22.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
3.2 | 60.0 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
3.1 | 78.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
3.1 | 3.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
3.1 | 34.1 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
3.1 | 12.4 | GO:0044194 | cytolytic granule(GO:0044194) |
3.0 | 6.0 | GO:0000346 | transcription export complex(GO:0000346) |
3.0 | 14.9 | GO:0098536 | deuterosome(GO:0098536) |
3.0 | 5.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
3.0 | 3.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
2.9 | 44.0 | GO:0035102 | PRC1 complex(GO:0035102) |
2.9 | 14.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
2.9 | 267.4 | GO:0016363 | nuclear matrix(GO:0016363) |
2.9 | 8.6 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
2.9 | 20.1 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
2.9 | 22.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
2.8 | 5.7 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
2.8 | 42.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
2.8 | 67.4 | GO:0000785 | chromatin(GO:0000785) |
2.8 | 707.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
2.7 | 11.0 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
2.7 | 16.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
2.7 | 8.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
2.7 | 8.1 | GO:0071914 | prominosome(GO:0071914) |
2.7 | 8.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
2.6 | 26.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
2.6 | 68.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
2.6 | 12.8 | GO:0032389 | MutLalpha complex(GO:0032389) |
2.6 | 12.8 | GO:0005642 | annulate lamellae(GO:0005642) |
2.6 | 10.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
2.6 | 222.5 | GO:0016605 | PML body(GO:0016605) |
2.6 | 7.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
2.5 | 592.8 | GO:0000790 | nuclear chromatin(GO:0000790) |
2.5 | 30.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
2.5 | 5.0 | GO:0071942 | XPC complex(GO:0071942) |
2.5 | 7.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
2.4 | 14.5 | GO:0034399 | nuclear periphery(GO:0034399) |
2.4 | 76.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
2.4 | 11.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
2.4 | 7.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
2.4 | 286.7 | GO:0001650 | fibrillar center(GO:0001650) |
2.3 | 7.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
2.3 | 198.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
2.3 | 7.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
2.3 | 11.6 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
2.3 | 6.9 | GO:0044299 | C-fiber(GO:0044299) |
2.3 | 4.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
2.3 | 6.8 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
2.3 | 11.4 | GO:0005915 | zonula adherens(GO:0005915) |
2.3 | 90.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
2.2 | 20.2 | GO:0070187 | telosome(GO:0070187) |
2.2 | 11.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
2.2 | 4.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
2.2 | 6.7 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
2.2 | 37.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
2.2 | 6.6 | GO:0043511 | inhibin complex(GO:0043511) |
2.2 | 17.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
2.2 | 8.8 | GO:0000803 | sex chromosome(GO:0000803) |
2.2 | 19.6 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
2.2 | 13.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
2.2 | 8.6 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
2.2 | 21.5 | GO:0070652 | HAUS complex(GO:0070652) |
2.1 | 14.4 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
2.0 | 52.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
2.0 | 6.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
2.0 | 14.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
2.0 | 75.1 | GO:0005871 | kinesin complex(GO:0005871) |
2.0 | 9.8 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.9 | 9.6 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.9 | 73.1 | GO:0016235 | aggresome(GO:0016235) |
1.9 | 30.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
1.9 | 20.8 | GO:0042611 | MHC protein complex(GO:0042611) |
1.9 | 24.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.9 | 24.1 | GO:0097542 | ciliary tip(GO:0097542) |
1.8 | 7.3 | GO:0045120 | pronucleus(GO:0045120) |
1.8 | 20.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.8 | 20.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
1.8 | 39.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
1.8 | 3.6 | GO:1990879 | CST complex(GO:1990879) |
1.8 | 14.2 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
1.8 | 1.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.8 | 88.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
1.7 | 47.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.7 | 6.8 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
1.7 | 15.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.7 | 10.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.7 | 10.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
1.7 | 1.7 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
1.6 | 35.9 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
1.6 | 27.0 | GO:0036038 | MKS complex(GO:0036038) |
1.6 | 11.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.6 | 37.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
1.6 | 48.6 | GO:0060170 | ciliary membrane(GO:0060170) |
1.6 | 97.9 | GO:0031526 | brush border membrane(GO:0031526) |
1.5 | 24.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
1.5 | 24.7 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
1.5 | 28.9 | GO:0005614 | interstitial matrix(GO:0005614) |
1.5 | 12.1 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
1.5 | 15.1 | GO:0051233 | spindle midzone(GO:0051233) |
1.5 | 21.0 | GO:0045178 | basal part of cell(GO:0045178) |
1.5 | 7.4 | GO:1990130 | Iml1 complex(GO:1990130) |
1.5 | 58.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
1.5 | 32.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
1.5 | 20.4 | GO:0035861 | site of double-strand break(GO:0035861) |
1.5 | 56.8 | GO:0005903 | brush border(GO:0005903) |
1.4 | 10.1 | GO:0042587 | glycogen granule(GO:0042587) |
1.4 | 7.2 | GO:0042581 | specific granule(GO:0042581) |
1.4 | 9.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
1.4 | 4.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.4 | 4.2 | GO:0005745 | m-AAA complex(GO:0005745) |
1.4 | 4.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
1.4 | 18.2 | GO:0031519 | PcG protein complex(GO:0031519) |
1.4 | 105.1 | GO:0005604 | basement membrane(GO:0005604) |
1.4 | 2.8 | GO:0016589 | NURF complex(GO:0016589) |
1.4 | 32.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
1.4 | 7.0 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
1.4 | 88.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
1.4 | 79.8 | GO:0005811 | lipid particle(GO:0005811) |
1.4 | 9.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
1.4 | 41.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
1.4 | 9.5 | GO:0071439 | clathrin complex(GO:0071439) |
1.4 | 5.4 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
1.3 | 1.3 | GO:0030870 | Mre11 complex(GO:0030870) |
1.3 | 6.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
1.3 | 22.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.3 | 3.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.3 | 10.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.3 | 3.8 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
1.3 | 27.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
1.3 | 72.9 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
1.2 | 3.7 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
1.2 | 13.4 | GO:0030904 | retromer complex(GO:0030904) |
1.2 | 232.7 | GO:0031965 | nuclear membrane(GO:0031965) |
1.2 | 3.6 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
1.2 | 24.2 | GO:0042629 | mast cell granule(GO:0042629) |
1.2 | 7.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.2 | 16.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.2 | 79.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
1.2 | 7.0 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
1.1 | 2.3 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
1.1 | 10.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.1 | 66.0 | GO:0030496 | midbody(GO:0030496) |
1.1 | 4.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.1 | 5.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.0 | 40.5 | GO:0005814 | centriole(GO:0005814) |
1.0 | 8.9 | GO:0030914 | STAGA complex(GO:0030914) |
1.0 | 21.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
1.0 | 2.9 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.0 | 1.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.9 | 21.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.9 | 22.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.9 | 24.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.9 | 1.8 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.9 | 40.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.9 | 59.1 | GO:0045095 | keratin filament(GO:0045095) |
0.9 | 0.9 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.9 | 0.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.9 | 51.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.9 | 10.5 | GO:0031902 | late endosome membrane(GO:0031902) |
0.9 | 25.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.9 | 1.7 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.9 | 28.1 | GO:0016592 | mediator complex(GO:0016592) |
0.8 | 4.2 | GO:0071010 | U2-type prespliceosome(GO:0071004) prespliceosome(GO:0071010) |
0.8 | 24.6 | GO:0005902 | microvillus(GO:0005902) |
0.8 | 0.8 | GO:0044447 | axoneme part(GO:0044447) |
0.8 | 1.7 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) post-mRNA release spliceosomal complex(GO:0071014) |
0.8 | 33.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.8 | 4.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.8 | 3.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.8 | 65.4 | GO:0001726 | ruffle(GO:0001726) |
0.8 | 12.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.8 | 2.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.8 | 14.2 | GO:0000145 | exocyst(GO:0000145) |
0.8 | 273.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.8 | 4.7 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.8 | 3.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.8 | 3.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.8 | 46.6 | GO:0000922 | spindle pole(GO:0000922) |
0.8 | 2.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.8 | 176.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.8 | 35.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.8 | 24.3 | GO:0015030 | Cajal body(GO:0015030) |
0.8 | 3.0 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.8 | 43.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.8 | 2.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.7 | 4.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.7 | 3.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.7 | 2.2 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.7 | 2.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.7 | 8.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.7 | 44.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.7 | 7.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.7 | 3.5 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.7 | 2.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.7 | 4.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.7 | 2.7 | GO:0031417 | NatC complex(GO:0031417) |
0.7 | 10.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.7 | 2.6 | GO:0071797 | LUBAC complex(GO:0071797) |
0.6 | 1.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.6 | 3.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.6 | 0.6 | GO:0005712 | chiasma(GO:0005712) |
0.6 | 6.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.6 | 6.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.6 | 2.9 | GO:0036157 | outer dynein arm(GO:0036157) |
0.6 | 46.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.6 | 19.4 | GO:0030286 | dynein complex(GO:0030286) |
0.5 | 2.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.5 | 10.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.5 | 7.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 1.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.5 | 4.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.5 | 1.5 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.5 | 3.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.5 | 3.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.5 | 1.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 14.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.5 | 6.6 | GO:0055029 | nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.5 | 4.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.5 | 9.0 | GO:0097228 | sperm principal piece(GO:0097228) |
0.4 | 1.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 3.4 | GO:0005839 | proteasome core complex(GO:0005839) |
0.4 | 2.9 | GO:0031932 | TORC2 complex(GO:0031932) |
0.4 | 2.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 11.2 | GO:0016459 | myosin complex(GO:0016459) |
0.4 | 123.3 | GO:0016604 | nuclear body(GO:0016604) |
0.4 | 1.8 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 1.0 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.3 | 0.7 | GO:0055087 | Ski complex(GO:0055087) |
0.3 | 2.2 | GO:0019013 | viral nucleocapsid(GO:0019013) |
0.3 | 0.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 5.3 | GO:0005912 | adherens junction(GO:0005912) anchoring junction(GO:0070161) |
0.3 | 11.6 | GO:0036126 | sperm flagellum(GO:0036126) |
0.3 | 2.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 4.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.3 | 3.7 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 0.5 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 373.3 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 9.6 | GO:0005819 | spindle(GO:0005819) |
0.2 | 0.2 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 0.5 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 0.5 | GO:0033557 | Slx1-Slx4 complex(GO:0033557) |
0.2 | 238.1 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 3.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 1.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 1.0 | GO:0031082 | BLOC complex(GO:0031082) |
0.1 | 0.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 1.8 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 2.4 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.2 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
26.4 | 158.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
22.9 | 68.6 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
22.5 | 67.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
19.8 | 59.4 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
18.3 | 55.0 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
18.3 | 73.3 | GO:0045159 | myosin II binding(GO:0045159) |
17.6 | 317.2 | GO:0044548 | S100 protein binding(GO:0044548) |
16.9 | 50.7 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
16.3 | 49.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
14.9 | 118.9 | GO:0052834 | inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
14.0 | 41.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
13.6 | 135.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
13.2 | 79.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
12.7 | 38.0 | GO:0097677 | STAT family protein binding(GO:0097677) |
12.3 | 49.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
12.0 | 131.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
11.9 | 35.8 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
11.7 | 70.2 | GO:0017040 | ceramidase activity(GO:0017040) |
11.5 | 57.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
11.3 | 45.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
11.1 | 66.4 | GO:0019976 | interleukin-2 binding(GO:0019976) |
11.0 | 43.8 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
10.5 | 94.4 | GO:0043495 | protein anchor(GO:0043495) |
10.3 | 41.4 | GO:0042610 | CD8 receptor binding(GO:0042610) |
10.3 | 93.1 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
10.1 | 40.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
10.0 | 80.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
10.0 | 59.9 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
10.0 | 10.0 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
9.8 | 29.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
9.7 | 48.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
9.5 | 38.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
9.2 | 45.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
9.1 | 45.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
9.0 | 170.6 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
9.0 | 26.9 | GO:0031720 | haptoglobin binding(GO:0031720) |
8.8 | 35.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
8.7 | 26.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
8.7 | 87.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
8.4 | 8.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
8.4 | 25.2 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
8.4 | 41.9 | GO:0015168 | polyol transmembrane transporter activity(GO:0015166) glycerol transmembrane transporter activity(GO:0015168) |
8.3 | 132.2 | GO:0008143 | poly(A) binding(GO:0008143) |
8.1 | 32.4 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
8.0 | 31.8 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
7.8 | 54.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
7.8 | 31.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
7.7 | 69.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
7.6 | 60.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
7.5 | 59.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
7.4 | 59.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
7.4 | 29.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
7.4 | 44.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
7.4 | 44.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
7.2 | 50.5 | GO:0003896 | DNA primase activity(GO:0003896) |
7.2 | 93.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
7.2 | 21.6 | GO:0048030 | disaccharide binding(GO:0048030) |
7.2 | 21.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
7.1 | 21.4 | GO:0038132 | neuregulin binding(GO:0038132) |
7.1 | 7.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
7.0 | 21.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
7.0 | 91.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
7.0 | 27.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
7.0 | 20.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
6.9 | 27.7 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
6.8 | 40.8 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
6.8 | 88.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
6.7 | 20.1 | GO:0019959 | interleukin-8 receptor activity(GO:0004918) interleukin-8 binding(GO:0019959) |
6.7 | 153.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
6.6 | 19.8 | GO:0031249 | denatured protein binding(GO:0031249) |
6.6 | 26.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
6.5 | 216.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
6.5 | 26.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
6.5 | 32.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
6.5 | 122.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
6.4 | 25.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
6.3 | 31.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
6.3 | 50.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
6.3 | 18.9 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
6.2 | 80.8 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
6.2 | 37.0 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
6.1 | 30.3 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
6.0 | 18.0 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
6.0 | 155.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
5.9 | 23.5 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
5.9 | 35.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
5.8 | 23.3 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
5.8 | 192.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
5.8 | 5.8 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
5.7 | 34.4 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
5.7 | 17.2 | GO:0016403 | dimethylargininase activity(GO:0016403) |
5.7 | 39.8 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
5.7 | 17.0 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
5.6 | 11.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
5.6 | 16.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
5.6 | 22.4 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
5.6 | 16.8 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
5.6 | 50.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
5.5 | 22.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
5.5 | 32.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
5.4 | 32.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
5.4 | 32.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
5.4 | 43.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
5.4 | 59.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
5.3 | 26.7 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
5.3 | 52.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
5.2 | 10.4 | GO:0031762 | follicle-stimulating hormone receptor binding(GO:0031762) |
5.2 | 20.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
5.2 | 31.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
5.1 | 5.1 | GO:0035877 | death effector domain binding(GO:0035877) |
5.1 | 5.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
5.1 | 51.1 | GO:0051400 | BH domain binding(GO:0051400) |
5.1 | 30.6 | GO:0045545 | syndecan binding(GO:0045545) |
5.1 | 75.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
5.0 | 30.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
5.0 | 15.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
5.0 | 5.0 | GO:0043398 | HLH domain binding(GO:0043398) |
5.0 | 15.0 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
5.0 | 15.0 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
4.9 | 14.8 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
4.9 | 14.7 | GO:0046592 | polyamine oxidase activity(GO:0046592) |
4.9 | 53.7 | GO:0070513 | death domain binding(GO:0070513) |
4.9 | 14.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
4.8 | 14.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
4.7 | 33.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
4.7 | 4.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
4.7 | 9.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
4.7 | 37.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
4.7 | 9.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
4.7 | 23.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
4.7 | 56.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
4.6 | 46.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
4.6 | 13.9 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
4.6 | 18.5 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
4.6 | 13.9 | GO:0070012 | oligopeptidase activity(GO:0070012) |
4.6 | 23.0 | GO:1990254 | keratin filament binding(GO:1990254) |
4.6 | 18.4 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
4.6 | 32.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
4.5 | 40.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
4.5 | 9.1 | GO:0035939 | microsatellite binding(GO:0035939) |
4.5 | 58.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
4.5 | 67.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
4.5 | 22.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
4.4 | 4.4 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
4.4 | 17.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
4.4 | 21.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
4.4 | 100.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
4.4 | 34.9 | GO:0030274 | LIM domain binding(GO:0030274) |
4.4 | 69.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
4.3 | 13.0 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
4.3 | 25.9 | GO:0004568 | chitinase activity(GO:0004568) |
4.3 | 8.6 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
4.3 | 17.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
4.3 | 12.9 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
4.3 | 64.0 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
4.2 | 12.7 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
4.2 | 50.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
4.2 | 16.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
4.2 | 12.6 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
4.1 | 28.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
4.1 | 12.4 | GO:0070835 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) nickel cation transmembrane transporter activity(GO:0015099) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) chromium ion transmembrane transporter activity(GO:0070835) |
4.1 | 8.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
4.1 | 16.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
4.0 | 12.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
4.0 | 20.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
4.0 | 12.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
4.0 | 48.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
4.0 | 100.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
4.0 | 35.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
4.0 | 118.9 | GO:0050699 | WW domain binding(GO:0050699) |
4.0 | 11.9 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
3.9 | 55.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
3.9 | 7.9 | GO:0051425 | PTB domain binding(GO:0051425) |
3.9 | 47.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
3.9 | 11.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
3.9 | 39.2 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
3.9 | 7.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
3.9 | 42.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
3.9 | 61.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
3.9 | 27.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
3.9 | 27.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
3.8 | 11.4 | GO:0004655 | porphobilinogen synthase activity(GO:0004655) |
3.8 | 15.2 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
3.8 | 11.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
3.8 | 18.9 | GO:0031404 | chloride ion binding(GO:0031404) |
3.8 | 146.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
3.8 | 86.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
3.7 | 11.2 | GO:0019809 | spermidine binding(GO:0019809) |
3.7 | 114.8 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
3.7 | 14.8 | GO:0019863 | IgE binding(GO:0019863) |
3.6 | 36.4 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
3.6 | 32.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
3.6 | 21.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
3.6 | 53.3 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
3.5 | 3.5 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
3.5 | 14.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
3.5 | 10.5 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
3.4 | 10.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
3.4 | 10.3 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
3.4 | 10.3 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
3.4 | 10.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
3.4 | 13.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
3.4 | 20.5 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
3.4 | 27.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
3.4 | 68.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
3.4 | 13.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
3.4 | 13.4 | GO:0050733 | RS domain binding(GO:0050733) |
3.3 | 10.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
3.3 | 10.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
3.3 | 13.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
3.3 | 13.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
3.3 | 192.9 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
3.3 | 10.0 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
3.3 | 63.0 | GO:0030371 | translation repressor activity(GO:0030371) |
3.3 | 13.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
3.3 | 66.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
3.3 | 36.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
3.2 | 32.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
3.2 | 22.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
3.2 | 35.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
3.2 | 12.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
3.2 | 35.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
3.2 | 22.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
3.2 | 31.8 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
3.2 | 50.7 | GO:0005522 | profilin binding(GO:0005522) |
3.2 | 15.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
3.2 | 15.8 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
3.1 | 6.3 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
3.1 | 15.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
3.1 | 15.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
3.1 | 12.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
3.1 | 28.2 | GO:0015250 | water channel activity(GO:0015250) |
3.1 | 15.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
3.1 | 15.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
3.1 | 18.7 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
3.1 | 9.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
3.1 | 12.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
3.1 | 49.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
3.1 | 27.7 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
3.1 | 15.3 | GO:0043515 | kinetochore binding(GO:0043515) |
3.1 | 177.7 | GO:0035064 | methylated histone binding(GO:0035064) |
3.1 | 9.2 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
3.1 | 42.7 | GO:0031491 | nucleosome binding(GO:0031491) |
3.0 | 12.2 | GO:0032052 | bile acid binding(GO:0032052) |
3.0 | 6.0 | GO:0015265 | urea channel activity(GO:0015265) |
3.0 | 368.2 | GO:0042393 | histone binding(GO:0042393) |
3.0 | 3.0 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
3.0 | 15.0 | GO:0070401 | NADP+ binding(GO:0070401) |
3.0 | 27.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
3.0 | 26.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
3.0 | 38.7 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
3.0 | 8.9 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
3.0 | 32.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
3.0 | 11.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
2.9 | 40.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
2.9 | 61.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
2.9 | 5.8 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
2.9 | 11.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.9 | 2.9 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
2.9 | 5.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
2.8 | 8.5 | GO:0004335 | galactokinase activity(GO:0004335) |
2.8 | 25.5 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
2.8 | 5.6 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
2.8 | 75.8 | GO:0035326 | enhancer binding(GO:0035326) |
2.8 | 8.3 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
2.8 | 8.3 | GO:0004522 | ribonuclease A activity(GO:0004522) |
2.7 | 2.7 | GO:0009041 | uridylate kinase activity(GO:0009041) |
2.7 | 19.0 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
2.7 | 10.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
2.7 | 24.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
2.7 | 5.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
2.7 | 26.8 | GO:0019864 | IgG binding(GO:0019864) |
2.7 | 10.7 | GO:0043199 | sulfate binding(GO:0043199) |
2.7 | 53.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
2.6 | 5.3 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
2.6 | 52.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
2.6 | 18.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
2.6 | 28.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
2.6 | 7.8 | GO:0047522 | 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
2.6 | 7.8 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
2.6 | 5.2 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
2.6 | 7.7 | GO:0042806 | fucose binding(GO:0042806) |
2.6 | 2.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
2.6 | 25.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
2.5 | 5.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
2.5 | 25.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
2.5 | 7.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
2.5 | 10.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
2.5 | 10.1 | GO:0008430 | selenium binding(GO:0008430) |
2.5 | 10.1 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
2.5 | 17.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
2.5 | 15.0 | GO:0034452 | dynactin binding(GO:0034452) |
2.5 | 10.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
2.5 | 29.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
2.5 | 459.0 | GO:0061135 | endopeptidase regulator activity(GO:0061135) |
2.5 | 34.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
2.5 | 9.9 | GO:0008265 | Mo-molybdopterin cofactor sulfurase activity(GO:0008265) |
2.5 | 5.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
2.5 | 34.6 | GO:0001618 | virus receptor activity(GO:0001618) |
2.5 | 17.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
2.4 | 24.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
2.4 | 14.7 | GO:0050700 | CARD domain binding(GO:0050700) |
2.4 | 7.3 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
2.4 | 7.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
2.4 | 9.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
2.4 | 9.7 | GO:0034618 | arginine binding(GO:0034618) |
2.4 | 21.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
2.4 | 67.1 | GO:0003785 | actin monomer binding(GO:0003785) |
2.4 | 26.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
2.4 | 54.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
2.4 | 94.2 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
2.4 | 54.1 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) |
2.3 | 105.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
2.3 | 37.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
2.3 | 14.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
2.3 | 120.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
2.3 | 71.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
2.3 | 2.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
2.3 | 6.9 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
2.3 | 13.7 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
2.3 | 11.4 | GO:0048185 | activin binding(GO:0048185) |
2.3 | 9.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
2.3 | 2.3 | GO:0016972 | thiol oxidase activity(GO:0016972) |
2.3 | 63.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
2.3 | 9.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
2.3 | 22.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
2.3 | 9.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
2.2 | 15.7 | GO:0004630 | phospholipase D activity(GO:0004630) |
2.2 | 26.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
2.2 | 29.0 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
2.2 | 13.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
2.2 | 41.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
2.2 | 225.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
2.2 | 6.5 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
2.2 | 23.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
2.2 | 325.9 | GO:0001047 | core promoter binding(GO:0001047) |
2.2 | 34.6 | GO:0005537 | mannose binding(GO:0005537) |
2.1 | 12.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
2.1 | 8.5 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
2.1 | 8.5 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
2.1 | 6.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
2.1 | 6.3 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
2.1 | 239.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
2.1 | 18.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
2.1 | 16.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
2.1 | 6.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
2.1 | 2.1 | GO:0004096 | catalase activity(GO:0004096) |
2.1 | 10.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
2.1 | 67.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
2.0 | 48.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
2.0 | 2.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
2.0 | 6.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
2.0 | 6.0 | GO:0070976 | TIR domain binding(GO:0070976) |
2.0 | 490.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
2.0 | 4.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
2.0 | 14.0 | GO:0004064 | arylesterase activity(GO:0004064) |
2.0 | 6.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
2.0 | 87.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
2.0 | 13.9 | GO:0033691 | sialic acid binding(GO:0033691) |
2.0 | 15.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
2.0 | 25.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
2.0 | 9.8 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
2.0 | 11.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.9 | 9.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.9 | 7.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.9 | 9.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
1.9 | 5.8 | GO:0030977 | taurine binding(GO:0030977) |
1.9 | 15.2 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.9 | 24.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.9 | 11.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
1.9 | 9.4 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
1.9 | 3.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
1.9 | 5.6 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
1.9 | 15.0 | GO:1990405 | protein antigen binding(GO:1990405) |
1.9 | 3.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.9 | 1.9 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
1.8 | 42.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.8 | 5.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.8 | 1.8 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
1.8 | 5.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.8 | 18.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.8 | 8.9 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.8 | 17.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
1.8 | 5.4 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
1.8 | 35.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
1.7 | 7.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.7 | 7.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.7 | 5.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.7 | 39.8 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
1.7 | 6.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.7 | 15.2 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
1.7 | 37.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
1.7 | 5.0 | GO:0097617 | annealing activity(GO:0097617) |
1.7 | 6.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.7 | 5.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.7 | 59.7 | GO:0002039 | p53 binding(GO:0002039) |
1.7 | 18.2 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
1.7 | 6.6 | GO:0034711 | inhibin binding(GO:0034711) |
1.7 | 6.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.7 | 29.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
1.6 | 8.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.6 | 4.9 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.6 | 8.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.6 | 61.5 | GO:0033613 | activating transcription factor binding(GO:0033613) |
1.6 | 8.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.6 | 3.2 | GO:0055100 | adiponectin binding(GO:0055100) |
1.6 | 14.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.6 | 17.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.6 | 401.4 | GO:0045296 | cadherin binding(GO:0045296) |
1.6 | 20.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.6 | 7.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
1.6 | 105.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
1.6 | 3.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.6 | 29.5 | GO:0070840 | dynein complex binding(GO:0070840) |
1.5 | 10.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.5 | 12.3 | GO:0015232 | heme transporter activity(GO:0015232) |
1.5 | 4.6 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.5 | 16.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
1.5 | 51.3 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
1.5 | 34.6 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
1.5 | 1.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.5 | 4.5 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.5 | 5.9 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
1.5 | 7.3 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
1.5 | 8.7 | GO:0070492 | oligosaccharide binding(GO:0070492) |
1.5 | 4.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.5 | 13.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
1.4 | 34.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.4 | 29.9 | GO:0031593 | polyubiquitin binding(GO:0031593) |
1.4 | 45.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
1.4 | 4.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.4 | 4.2 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
1.4 | 26.7 | GO:0001968 | fibronectin binding(GO:0001968) |
1.4 | 8.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
1.4 | 1.4 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
1.4 | 68.0 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
1.4 | 6.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.4 | 8.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.4 | 9.6 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.4 | 549.9 | GO:0000975 | regulatory region DNA binding(GO:0000975) |
1.4 | 4.1 | GO:0051870 | methotrexate binding(GO:0051870) |
1.4 | 13.6 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
1.4 | 23.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
1.4 | 238.2 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
1.4 | 6.8 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
1.3 | 157.8 | GO:0051015 | actin filament binding(GO:0051015) |
1.3 | 4.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.3 | 9.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.3 | 1.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.3 | 4.0 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
1.3 | 27.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.3 | 5.3 | GO:0019002 | GMP binding(GO:0019002) |
1.3 | 4.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.3 | 17.1 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
1.3 | 3.9 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.3 | 32.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
1.3 | 10.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
1.3 | 3.8 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
1.3 | 6.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
1.3 | 33.0 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
1.3 | 10.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.3 | 12.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
1.2 | 11.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.2 | 9.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
1.2 | 24.3 | GO:0008199 | ferric iron binding(GO:0008199) |
1.2 | 19.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.2 | 12.1 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.2 | 7.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
1.2 | 38.3 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
1.2 | 13.1 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
1.2 | 9.6 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.2 | 4.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.2 | 4.7 | GO:0031386 | protein tag(GO:0031386) |
1.2 | 3.5 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
1.2 | 4.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.2 | 4.7 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
1.2 | 22.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.1 | 33.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
1.1 | 3.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
1.1 | 121.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
1.1 | 6.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.1 | 13.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.1 | 58.1 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
1.1 | 8.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.1 | 5.4 | GO:0004586 | ornithine decarboxylase activity(GO:0004586) |
1.1 | 41.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.1 | 7.5 | GO:0005113 | patched binding(GO:0005113) |
1.1 | 2.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.1 | 5.3 | GO:0004962 | endothelin receptor activity(GO:0004962) |
1.0 | 10.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.0 | 1.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.0 | 1.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
1.0 | 22.6 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
1.0 | 2.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.0 | 26.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
1.0 | 6.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.0 | 3.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
1.0 | 20.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.0 | 3.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.0 | 6.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
1.0 | 3.0 | GO:0004775 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
1.0 | 2.9 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.9 | 2.8 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.9 | 7.4 | GO:0042287 | MHC protein binding(GO:0042287) |
0.9 | 4.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.9 | 13.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.9 | 13.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.9 | 13.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.9 | 2.7 | GO:0052871 | leukotriene-B4 20-monooxygenase activity(GO:0050051) tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
0.9 | 3.6 | GO:0047619 | acylcarnitine hydrolase activity(GO:0047619) |
0.9 | 1.8 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.9 | 2.6 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.9 | 11.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.9 | 1.8 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.9 | 4.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.9 | 3.5 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.9 | 8.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.9 | 1.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.9 | 1.7 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.9 | 18.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.9 | 4.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.8 | 171.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.8 | 5.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.8 | 11.4 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.8 | 2.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.8 | 16.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.8 | 2.4 | GO:0017168 | 5-oxoprolinase (ATP-hydrolyzing) activity(GO:0017168) |
0.8 | 3.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.8 | 22.7 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.8 | 2.3 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.8 | 3.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.8 | 3.8 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.8 | 56.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.7 | 3.7 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.7 | 8.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.7 | 5.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.7 | 2.2 | GO:0052724 | inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.7 | 12.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.7 | 7.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.7 | 5.0 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.7 | 1.4 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.7 | 4.2 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.7 | 2.1 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
0.7 | 9.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.7 | 19.0 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.7 | 2.0 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.7 | 1.3 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.7 | 3.3 | GO:0015142 | tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.7 | 125.5 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.7 | 9.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.6 | 3.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.6 | 3.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.6 | 1.9 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.6 | 4.9 | GO:0015926 | glucosidase activity(GO:0015926) |
0.6 | 9.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.6 | 3.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.6 | 3.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.6 | 4.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.6 | 5.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.6 | 6.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.6 | 2.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.6 | 3.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.6 | 2.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.6 | 1.7 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.5 | 9.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.5 | 1.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.5 | 5.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.5 | 1.5 | GO:0045340 | mercury ion binding(GO:0045340) |
0.5 | 6.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.5 | 0.5 | GO:0009384 | N-acylmannosamine kinase activity(GO:0009384) |
0.5 | 11.3 | GO:0003774 | motor activity(GO:0003774) |
0.5 | 45.1 | GO:0003682 | chromatin binding(GO:0003682) |
0.5 | 4.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.5 | 4.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.5 | 3.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.5 | 8.0 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 21.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.5 | 1.4 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.5 | 12.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.4 | 3.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.4 | 3.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.4 | 51.8 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.4 | 0.9 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.4 | 0.8 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 0.8 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.4 | 1.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.4 | 5.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.4 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.4 | 31.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.4 | 4.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.4 | 8.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 2.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.4 | 19.3 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.4 | 1.8 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.4 | 1.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.4 | 1.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.3 | 72.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 1.4 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 6.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 7.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.3 | 27.9 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.3 | 1.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 113.3 | GO:0003677 | DNA binding(GO:0003677) |
0.3 | 0.6 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.3 | 1.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.3 | 9.5 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.3 | 3.0 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.3 | 2.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.3 | 8.8 | GO:0004601 | peroxidase activity(GO:0004601) |
0.3 | 0.5 | GO:0033192 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 0.8 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.3 | 2.4 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 2.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 1.2 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 2.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 0.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.7 | GO:0003921 | GMP synthase activity(GO:0003921) GMP synthase (glutamine-hydrolyzing) activity(GO:0003922) |
0.2 | 9.9 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.2 | 3.6 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 1.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 2.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 2.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 2.2 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.2 | 6.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 0.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 3.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 0.7 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.2 | 7.5 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 1.4 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.2 | 1.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 0.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 198.5 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 0.9 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 1.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.3 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.1 | 1.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 0.7 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 5.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 1.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 0.2 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.0 | 0.1 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.9 | 35.8 | ST STAT3 PATHWAY | STAT3 Pathway |
11.1 | 33.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
10.9 | 32.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
9.2 | 101.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
9.2 | 165.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
8.6 | 77.8 | PID EPO PATHWAY | EPO signaling pathway |
8.4 | 8.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
8.3 | 24.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
8.1 | 234.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
8.0 | 88.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
8.0 | 48.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
7.8 | 117.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
7.7 | 506.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
7.7 | 245.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
7.6 | 30.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
7.5 | 59.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
7.4 | 22.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
7.2 | 100.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
7.1 | 121.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
7.0 | 42.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
6.9 | 208.3 | PID BCR 5PATHWAY | BCR signaling pathway |
6.9 | 200.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
6.9 | 179.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
6.9 | 109.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
6.6 | 132.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
6.6 | 98.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
6.6 | 255.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
6.4 | 212.1 | PID ARF6 PATHWAY | Arf6 signaling events |
6.4 | 31.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
6.3 | 94.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
6.2 | 12.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
6.2 | 56.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
6.2 | 18.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
5.6 | 56.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
5.6 | 111.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
5.5 | 66.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
5.4 | 177.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
5.3 | 80.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
5.3 | 21.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
5.2 | 67.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
5.2 | 257.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
5.0 | 210.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
5.0 | 30.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
5.0 | 225.4 | PID AURORA B PATHWAY | Aurora B signaling |
4.8 | 43.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
4.7 | 173.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
4.5 | 80.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
4.4 | 8.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
4.1 | 20.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
4.1 | 110.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
4.0 | 100.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
4.0 | 59.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
3.9 | 154.6 | PID PLK1 PATHWAY | PLK1 signaling events |
3.9 | 69.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
3.8 | 110.7 | PID ALK1 PATHWAY | ALK1 signaling events |
3.6 | 10.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
3.6 | 115.5 | PID BARD1 PATHWAY | BARD1 signaling events |
3.6 | 49.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
3.2 | 12.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
3.2 | 9.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
3.2 | 15.8 | PID ATR PATHWAY | ATR signaling pathway |
3.2 | 9.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
3.1 | 31.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
3.1 | 106.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
3.0 | 91.6 | PID E2F PATHWAY | E2F transcription factor network |
2.9 | 164.9 | PID NOTCH PATHWAY | Notch signaling pathway |
2.9 | 8.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
2.9 | 110.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
2.9 | 179.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
2.9 | 63.2 | PID INSULIN PATHWAY | Insulin Pathway |
2.9 | 94.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
2.8 | 65.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
2.6 | 50.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
2.6 | 102.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
2.6 | 26.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.6 | 23.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
2.6 | 126.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
2.6 | 7.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
2.5 | 89.0 | PID FGF PATHWAY | FGF signaling pathway |
2.5 | 112.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
2.5 | 25.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
2.3 | 86.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
2.3 | 9.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
2.3 | 30.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
2.3 | 36.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
2.3 | 228.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
2.2 | 17.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
2.2 | 19.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
2.2 | 28.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
2.2 | 15.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
2.1 | 66.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
2.1 | 25.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
1.9 | 3.9 | PID IGF1 PATHWAY | IGF1 pathway |
1.9 | 58.4 | PID P53 REGULATION PATHWAY | p53 pathway |
1.9 | 30.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
1.9 | 279.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.8 | 27.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
1.8 | 11.0 | PID MYC PATHWAY | C-MYC pathway |
1.8 | 378.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
1.7 | 13.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.7 | 8.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.6 | 8.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
1.6 | 15.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.5 | 89.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
1.5 | 13.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
1.5 | 24.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
1.4 | 2.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.4 | 34.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
1.4 | 20.5 | PID ATM PATHWAY | ATM pathway |
1.4 | 23.0 | PID RHOA PATHWAY | RhoA signaling pathway |
1.3 | 5.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
1.3 | 17.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
1.2 | 18.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.2 | 25.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
1.1 | 28.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
1.1 | 25.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.1 | 7.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.0 | 46.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
1.0 | 10.9 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.8 | 11.8 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.8 | 10.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.8 | 5.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.7 | 11.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.6 | 13.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.6 | 9.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.6 | 7.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.6 | 12.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.5 | 2.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.5 | 20.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.5 | 4.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.5 | 10.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.5 | 11.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 5.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 3.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.4 | 3.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.4 | 2.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 4.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 1.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 2.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 1.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 1.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 3.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.7 | 15.7 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
15.6 | 233.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
10.4 | 124.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
10.2 | 10.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
9.5 | 180.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
9.3 | 28.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
9.1 | 118.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
8.9 | 124.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
8.9 | 106.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
8.5 | 42.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
8.5 | 144.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
8.2 | 165.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
8.0 | 224.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
7.8 | 77.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
7.6 | 106.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
7.6 | 121.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
7.4 | 36.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
7.2 | 180.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
6.9 | 333.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
6.3 | 144.6 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
6.2 | 55.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
6.2 | 24.8 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
6.2 | 74.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
6.0 | 18.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
5.9 | 71.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
5.9 | 106.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
5.8 | 52.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
5.6 | 89.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
5.5 | 66.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
5.3 | 69.0 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
5.3 | 5.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
5.1 | 76.8 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
5.1 | 45.6 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
5.0 | 131.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
5.0 | 85.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
5.0 | 114.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
5.0 | 139.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
4.9 | 92.9 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
4.8 | 38.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
4.8 | 62.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
4.8 | 116.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
4.8 | 52.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
4.8 | 14.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
4.6 | 162.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
4.6 | 27.8 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
4.5 | 49.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
4.4 | 13.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
4.3 | 94.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
4.1 | 12.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
4.1 | 49.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
4.1 | 8.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
4.0 | 68.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
4.0 | 51.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
4.0 | 229.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
3.9 | 349.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
3.9 | 43.0 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
3.9 | 11.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
3.9 | 38.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
3.9 | 138.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
3.8 | 61.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
3.8 | 60.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
3.8 | 41.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
3.7 | 74.9 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
3.6 | 18.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
3.6 | 43.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
3.6 | 72.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
3.5 | 31.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
3.5 | 21.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
3.4 | 84.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
3.4 | 43.6 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
3.3 | 20.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
3.3 | 72.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
3.1 | 388.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
3.1 | 12.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
3.1 | 24.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
3.1 | 39.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
3.0 | 27.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
3.0 | 39.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
3.0 | 269.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
3.0 | 56.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
3.0 | 23.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
2.8 | 33.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
2.7 | 300.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
2.6 | 355.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
2.5 | 15.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
2.5 | 15.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
2.5 | 40.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
2.5 | 52.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
2.5 | 46.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
2.4 | 19.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
2.4 | 16.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
2.3 | 44.4 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
2.3 | 40.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
2.2 | 36.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
2.2 | 20.0 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
2.2 | 28.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
2.2 | 13.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
2.1 | 27.7 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
2.1 | 37.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
2.0 | 28.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
2.0 | 12.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
2.0 | 17.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
2.0 | 25.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.9 | 1.9 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
1.8 | 33.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
1.8 | 62.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
1.8 | 7.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
1.8 | 18.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.8 | 9.0 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
1.8 | 30.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.8 | 19.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.8 | 7.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.8 | 102.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
1.7 | 43.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
1.7 | 13.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.6 | 56.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
1.6 | 14.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
1.6 | 27.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.6 | 24.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.6 | 106.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.6 | 15.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
1.5 | 7.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
1.5 | 13.5 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
1.5 | 13.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.4 | 32.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
1.4 | 8.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
1.4 | 6.8 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
1.3 | 2.7 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
1.3 | 1.3 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
1.3 | 24.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.2 | 16.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.2 | 7.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
1.2 | 24.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
1.2 | 55.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.2 | 7.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.2 | 2.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.2 | 70.2 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
1.1 | 18.2 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
1.1 | 22.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
1.1 | 18.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
1.1 | 40.4 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
1.1 | 5.3 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
1.0 | 5.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.0 | 25.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
1.0 | 6.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.0 | 9.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.9 | 16.9 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.9 | 9.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.9 | 1.8 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.9 | 29.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.9 | 1.8 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.9 | 7.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.9 | 9.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.8 | 3.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.8 | 12.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.8 | 4.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.8 | 50.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.7 | 23.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.7 | 6.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.7 | 0.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 6.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.6 | 9.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.6 | 1.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.5 | 11.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.5 | 4.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.5 | 1.5 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.5 | 1.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.5 | 13.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.5 | 11.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.4 | 2.0 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.4 | 1.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.4 | 11.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 2.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 1.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.3 | 2.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 2.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 2.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.3 | 4.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 3.2 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.2 | 2.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 6.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 2.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 1.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 3.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 2.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 5.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.3 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |